(+)-artemisinin increases expression ISO Cyp1a2 (Mus musculus) 6480464 artemisinin results in increased expression of CYP1A2 mRNA CTD PMID:17962186 (+)-artemisinin increases expression EXP 6480464 artemisinin results in increased expression of CYP1A2 mRNA CTD PMID:16919048 (+)-artemisinin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 artemisinin results in decreased activity of CYP1A2 protein CTD PMID:11124226 (+)-catechin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA CTD PMID:25663641 (+)-epicatechin-3-O-gallate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA CTD PMID:25663641 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA] CTD PMID:31150632 (+/-)-Aegeline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 (-)-cotinine increases activity ISO CYP1A2 (Homo sapiens) 6480464 Cotinine results in increased activity of CYP1A2 protein CTD PMID:16203240 (-)-cotinine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Cotinine results in decreased activity of CYP1A2 protein CTD PMID:15916432 (-)-epigallocatechin 3-gallate affects binding EXP 6480464 epigallocatechin gallate binds to CYP1A2 protein CTD PMID:23010222 (-)-epigallocatechin 3-gallate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA CTD PMID:25663641 (-)-selegiline affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Selegiline CTD PMID:16198659 (-)-trans-epsilon-viniferin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 epsilon-viniferin results in decreased activity of CYP1A2 protein CTD PMID:12818727 (1->4)-beta-D-glucan multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP1A2 mRNA CTD PMID:36331819 (1E,4E,8E)-alpha-humulene decreases activity EXP 6480464 humulene results in decreased activity of CYP1A2 protein CTD PMID:29074051 (2-hydroxyphenyl)acetic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic acid CTD PMID:34334558 (E,E)-germacrone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 germacrone results in decreased activity of CYP1A2 protein CTD PMID:23850985 (R)-lipoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] CTD PMID:21932800 (R)-lipoic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 (R,R,R)-alpha-tocopherol increases activity EXP 6480464 alpha-Tocopherol results in increased activity of CYP1A2 protein CTD PMID:15665910 (R,R,R)-alpha-tocopherol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] CTD PMID:26102010 (RS)-coclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 (RS)-norcoclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 (S)-coclaurine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 (S)-duloxetine hydrochloride multiple interactions EXP 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine Hydrochloride and CYP1A2 protein results in increased activity of and results in increased glutathionylation of Duloxetine Hydrochloride CTD PMID:20669986 (S)-naringenin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 naringenin results in decreased activity of CYP1A2 protein CTD PMID:21053930 and PMID:29753067 (S)-nicotine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Nicotine results in increased expression of CYP1A2 protein CTD PMID:11849738 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP1A2 mRNA CTD PMID:26463278 (S)-nicotine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nicotine results in decreased activity of CYP1A2 protein CTD PMID:15916432 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of 1 more ... CTD PMID:9733665 1,1,1-Trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 1 more ... CTD PMID:9047321 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO Cyp1a2 (Mus musculus) 6480464 o and p'-DDT affects the expression of CYP1A2 mRNA CTD PMID:18925944 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO CYP1A2 (Homo sapiens) 6480464 o and p'-DDT results in increased expression of CYP1A2 mRNA CTD PMID:21924250 1,1-bis(2-aminoethyl)-2-hydroxy-3-oxotriazane decreases activity EXP 6480464 2 and 2'-(hydroxynitrosohydrazono)bis-ethanamine results in decreased activity of CYP1A2 protein CTD PMID:15542068 1,2,3,7,8-Pentachlorodibenzodioxin increases expression ISO Cyp1a2 (Mus musculus) 6480464 1 more ... CTD PMID:23674508 1,2,3,7,8-Pentachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 1 more ... CTD PMID:24713691 1,2,4,5-tetrachlorobenzene increases expression EXP 6480464 1 more ... CTD PMID:10696772 1,2,4-trichlorobenzene increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 1 more ... CTD PMID:7747284 1,2-dichlorobenzene increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 2-dichlorobenzene CTD PMID:7747284 1,2-dichloroethane decreases expression ISO Cyp1a2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CYP1A2 mRNA CTD PMID:28189721 and PMID:28960355 1,2-dichloroethene affects expression EXP 6480464 1 and 2-dichloroethylene affects the expression of CYP1A2 protein CTD PMID:9493318 1,2-dichloroethene decreases activity EXP 6480464 1 and 2-dichloroethylene results in decreased activity of CYP1A2 protein CTD PMID:9671540 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP1A2 mRNA CTD PMID:32387197 1,2-dimethylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1 and 2-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 1,3,7-trimethyluric acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased chemical synthesis of 1 more ... CTD PMID:31132250 1,3-Dinitropyrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with POR protein] results in decreased metabolism of 1 and 3-dinitropyrene CTD PMID:11113705 1,3-Dinitropyrene affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 1 and 3-dinitropyrene CTD PMID:2180560 1,4-dichlorobenzene increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 4-dichlorobenzene CTD PMID:7747284 1,4-dimethylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1 and 4-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 1,4-naphthoquinone increases expression ISO CYP1A2 (Homo sapiens) 6480464 1 and 4-naphthoquinone results in increased expression of CYP1A2 mRNA CTD PMID:18602459 1,4-naphthoquinone increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1,6-dimethylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1 and 6-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 1,6-Dinitropyrene affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 1 and 6-dinitropyrene CTD PMID:2180560 1,7-dimethylxanthine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 1 and 7-dimethylxanthine CTD PMID:1302044 1,7-dimethylxanthine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased chemical synthesis of 1 more ... CTD PMID:19215233 and PMID:31132250 1,7-dimethylxanthine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 1 and 7-dimethylxanthine CTD PMID:19215233 1,7-dimethylxanthine increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 1 and 7-dimethylxanthine CTD PMID:15980104 1,7-dimethylxanthine increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of 1 and 7-dimethylxanthine CTD PMID:1302044 1,7-phenanthroline multiple interactions EXP 6480464 1 and 7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein] CTD PMID:17967931 1,7-phenanthroline increases expression EXP 6480464 1 and 7-phenanthroline results in increased expression of CYP1A2 protein CTD PMID:17967931 1,8-Dinitropyrene affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of 1 and 8-dinitropyrene CTD PMID:2180560 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 stiripentol results in decreased activity of CYP1A2 protein CTD PMID:16022579 1-Aminopyrene increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 1-aminopyrene CTD PMID:15728263 1-benzofuran decreases activity ISO CYP1A2 (Homo sapiens) 6480464 benzofuran analog results in decreased activity of CYP1A2 protein CTD PMID:15916432 1-hydroxyanthraquinone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1-hydroxyanthraquinone results in decreased activity of CYP1A2 protein CTD PMID:33438235 1-methyl-7H-xanthine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1-methylxanthine results in decreased activity of CYP1A2 protein CTD PMID:11465391 1-methyl-7H-xanthine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of 1 and 7-dimethylxanthine] which results in increased chemical synthesis of 1-methylxanthine CTD PMID:19215233 1-methylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1-methylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 1-Methylpyrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with SULT1A1 protein] results in increased susceptibility to 1-methylpyrene CTD PMID:33035519 1-naphthol increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 1-naphthol CTD PMID:16243959 1-naphthol affects binding ISO CYP1A2 (Homo sapiens) 6480464 1-naphthol binds to CYP1A2 protein CTD PMID:32278787 1-naphthol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1-naphthol results in decreased activity of CYP1A2 protein CTD PMID:15916432 1-naphthyl isothiocyanate multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:15598703 1-naphthyl isothiocyanate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:20551477 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:15598703 1-nitropyrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] and CYP1A2 affects the reaction [1-nitropyrene results in increased mutagenesis of HPRT1 gene] CTD PMID:10727902 and PMID:18493746 1-nitropyrene affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 affects the susceptibility to 1-nitropyrene CTD PMID:10727902 1-nitropyrene multiple interactions EXP 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 17alpha-ethynylestradiol increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Ethinyl Estradiol CTD PMID:15304426 17alpha-ethynylestradiol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased activity of CYP1A2 protein CTD PMID:18816299 17alpha-ethynylestradiol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine more ... CTD PMID:16198659 and PMID:16291717 17beta-estradiol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of CYP1A2 mRNA more ... CTD PMID:16790556 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CYP1A2 mRNA CTD PMID:31119341 and PMID:32145629 17beta-estradiol decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP1A2 mRNA CTD PMID:28357125 17beta-estradiol increases expression ISO CYP1A2 (Homo sapiens) 6480464 Estradiol results in increased expression of CYP1A2 mRNA CTD PMID:19619570 17beta-estradiol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Estradiol CTD PMID:16790556 17beta-estradiol increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Estradiol CTD PMID:15961252 2'-deoxyguanosine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein promotes the reaction [Aflatoxin B1 binds to Deoxyguanosine] and CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] CTD PMID:21907773 2,2',3,3',6,6'-hexachlorobiphenyl decreases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:28431184 2,2',3,3',6,6'-hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:28431184 2,2',4,4',5,5'-hexachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2 more ... CTD PMID:21571617 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:3302669 2,2',4,4',5,5'-hexachlorobiphenyl increases activity EXP 6480464 2 more ... CTD PMID:16835634 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:16835634 and PMID:17160104 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:20961953 and PMID:28433925 2,2',4,4',5,5'-hexachlorobiphenyl increases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:15743714 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:32679240 2,2',5,5'-tetrachlorobiphenyl increases expression ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:21703328 2,2',5,5'-tetrachlorobiphenyl affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the susceptibility to 2 more ... CTD PMID:27913846 2,3',4,4',5-Pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2 more ... CTD PMID:21571617 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:17342196 2,3',4,4',5-Pentachlorobiphenyl decreases activity EXP 6480464 2 more ... CTD PMID:15659567 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:23674508 2,3',4,4',5-Pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:10986007 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:18493746 2,3',4,4',5-Pentachlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:15659567 2,3',4,4',5-Pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:20961953 2,3,3',4,4',5,5'-Heptachlorobiphenyl increases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:15743714 2,3,3',4,4',5-Hexachlorobiphenyl multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:18493746 2,3,3',4,4',5-Hexachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:23674508 2,3,3',4,4',5-Hexachlorobiphenyl decreases activity EXP 6480464 2 more ... CTD PMID:15659567 2,3,3',4,4',5-Hexachlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:15659567 2,3,3',4,4',5-Hexachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:10986007 2,3,4,3',4'-Pentachlorobiphenyl multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:18493746 2,3,4,3',4'-Pentachlorobiphenyl decreases activity EXP 6480464 2 more ... CTD PMID:15659567 2,3,4,3',4'-Pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2 more ... CTD PMID:21571617 2,3,4,3',4'-Pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:10986007 2,3,4,3',4'-Pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:20961953 2,3,4,3',4'-Pentachlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:15659567 2,3,4,7,8-Pentachlorodibenzofuran multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17342195 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:20705892 2,3,4,7,8-Pentachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:23674508 and PMID:24713691 2,3,4,7,8-Pentachlorodibenzofuran increases activity EXP 6480464 2 more ... CTD PMID:17160103 and PMID:20705892 2,3,4,7,8-Pentachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:20705892 and PMID:21724226 2,3,4,7,8-Pentachlorodibenzofuran increases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:20705892 2,3,4,7,8-Pentachlorodibenzofuran affects abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the abundance of 2 more ... CTD PMID:10448125 and PMID:9240455 2,3,7,8-tetrabromodibenzodioxine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] more ... CTD PMID:11064004 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:20819909 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA and Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein CTD PMID:11064004 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity EXP 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:12062927 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP1A2 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA and Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein CTD PMID:10568693 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO CYP1A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:16426572 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:22298810 and PMID:31511937 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO CYP1A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP1A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein CTD PMID:10986007 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein CTD PMID:15659567 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 1-nitropyrene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] more ... CTD PMID:11585058 more ... 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Tetrachlorodibenzodioxin and CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:16636061 and PMID:21095216 2,3,7,8-tetrachlorodibenzodioxine affects abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin CTD PMID:10448125 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein affects the abundance of Tetrachlorodibenzodioxin] inhibits the reaction [CYP1A1 protein results in increased metabolism of Tetrachlorodibenzodioxin] more ... CTD PMID:11043581 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased activity of CYP1A2 protein CTD PMID:15659567 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:16636061 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP1A2 more ... CTD PMID:11043581 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:20705892 more ... 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:20702594 more ... 2,3,7,8-Tetrachlorodibenzofuran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 AHR protein promotes the reaction [2 more ... CTD PMID:25768209 2,3,7,8-Tetrachlorodibenzofuran increases activity EXP 6480464 2 more ... CTD PMID:20705892 2,3,7,8-Tetrachlorodibenzofuran increases activity ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:20705892 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:20705892 2,3-dihydrobenzofuran decreases activity ISO CYP1A2 (Homo sapiens) 6480464 coumaran results in decreased activity of CYP1A2 protein CTD PMID:15916432 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased activity of and results in decreased expression of CYP1A2 protein CTD PMID:18079364 2,4,6-Triphenyl-1-hexene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:18560529 2,4-D increases expression EXP 6480464 2 and 4-Dichlorophenoxyacetic Acid results in increased expression of CYP1A2 mRNA CTD PMID:10910964 2,4-diaminotoluene increases expression EXP 6480464 2 and 4-diaminotoluene results in increased expression of CYP1A2 protein CTD PMID:8685904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:22331496 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO CYP1A2 (Homo sapiens) 6480464 2 more ... CTD PMID:19270788 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 [CYP1A2 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 2 more ... CTD PMID:21673328 2,4-dinitrophenol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2 and 4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 2,4-dinitrophenol multiple interactions EXP 6480464 2 and 4-Dinitrophenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 2,6-dimethylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2 and 6-dimethylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP1A2 protein CTD PMID:18420780 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Praziquantel CTD PMID:12920490 2-acetamidofluorene increases hydrolysis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased hydrolysis of 2-Acetylaminofluorene CTD PMID:2334931 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CYP1A2 protein CTD PMID:28245158 2-acetamidofluorene increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 2-Acetylaminofluorene CTD PMID:15450435 2-acetamidofluorene affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-Acetylaminofluorene CTD PMID:2655891 2-acetamidofluorene increases expression ISO Cyp1a2 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA CTD PMID:16381673 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene analog results in decreased expression of CYP1A2 protein and 2-Acetylaminofluorene results in decreased expression of CYP1A2 protein CTD PMID:15916741 2-acetamidofluorene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I2 protein affects the reaction [2-Acetylaminofluorene results in increased expression of CYP1A2 mRNA] CTD PMID:16381673 2-amino-2-deoxy-D-galactopyranose decreases expression EXP 6480464 Galactosamine results in decreased expression of CYP1A2 protein CTD PMID:16208626 2-Amino-3-methyl-9H-pyrido[2,3-b]indole increases expression EXP 6480464 2-amino-3-methyl-9H-pyrido(2 more ... CTD PMID:8902619 2-Amino-3-methyl-9H-pyrido[2,3-b]indole increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-amino-3-methyl-9H-pyrido(2 and 3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 2-Amino-3-methyl-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2 more ... CTD PMID:8902619 2-Amino-3-methyl-9H-pyrido[2,3-b]indole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of and results in increased hydroxylation of 2-amino-3-methyl-9H-pyrido(2 more ... CTD PMID:14729582 and PMID:28160022 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4 and 6-dinitrotoluene affects the expression of CYP1A2 mRNA CTD PMID:21346803 2-Amino-9H-pyrido[2,3-b]indole multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased activity of 2-amino-9H-pyrido(2 and 3-b)indole CTD PMID:1913651 2-Amino-9H-pyrido[2,3-b]indole increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-amino-9H-pyrido(2 and 3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 2-Amino-9H-pyrido[2,3-b]indole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with NAT2 gene polymorphism] promotes the reaction [2-amino-9H-pyrido(2 more ... CTD PMID:1913651 more ... 2-benzoxazolinone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 benzoxazolone results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-chlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2-chlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-hydroxy-17beta-estradiol increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol CTD PMID:16790556 2-hydroxy-17beta-estradiol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] more ... CTD PMID:16790556 2-hydroxychrysophanol increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of 2-hydroxychrysophanol CTD PMID:29698620 2-hydroxychrysophanol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol CTD PMID:29698620 2-Methoxynaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2-methoxynaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-methyl-1H-indole increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-methylindole results in increased expression of CYP1A2 protein CTD PMID:31201936 2-methyl-6-(phenylethynyl)pyridine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 6-methyl-2-(phenylethynyl)pyridine results in decreased activity of CYP1A2 protein CTD PMID:15193955 2-methylnaphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2-methylnaphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-naphthol increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 2-naphthol CTD PMID:16243959 2-naphthol affects binding ISO CYP1A2 (Homo sapiens) 6480464 2-naphthol binds to CYP1A2 protein CTD PMID:32278787 2-naphthol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2-naphthol results in decreased activity of CYP1A2 protein CTD PMID:15916432 2-naphthylamine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 2-Naphthylamine CTD PMID:15450435 2-nitroanisole increases expression EXP 6480464 2-nitroanisole results in increased expression of CYP1A2 and 2-nitroanisole results in increased expression of CYP1A2 protein CTD PMID:11409192 and PMID:16601807 3,3',4,4',5-pentachlorobiphenyl increases expression ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:16049271 more ... 3,3',4,4',5-pentachlorobiphenyl affects expression ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:31563530 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:20702594 more ... 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:16049271 more ... 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:20961953 more ... 3,3',4,4',5-pentachlorobiphenyl increases activity EXP 6480464 3 more ... CTD PMID:16628245 3,3',4,4',5-pentachlorobiphenyl decreases activity EXP 6480464 3 more ... CTD PMID:15659567 3,3',4,4',5-pentachlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:15659567 3,3',4,4',5-pentachlorobiphenyl increases activity ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:10986007 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:12635099 more ... 3,3',4,4',5-pentachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3 more ... CTD PMID:21571617 3,3',4,4'-tetrachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3 more ... CTD PMID:21571617 3,3',4,4'-tetrachlorobiphenyl increases expression ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:31733235 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:12635099 3,3',4,4'-tetrachlorobiphenyl increases expression ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:12117779 and PMID:19467301 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:20961953 3,3',5-triiodo-L-thyronine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Triiodothyronine results in increased expression of CYP1A2 mRNA CTD PMID:28478156 3,3',5-triiodo-L-thyronine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Triiodothyronine affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] and Triiodothyronine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] CTD PMID:28478156 3,3'-diindolylmethane increases expression ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:15672752 and PMID:19770484 3,3'-diindolylmethane increases expression EXP 6480464 3 and 3'-diindolylmethane results in increased expression of CYP1A2 protein CTD PMID:8384853 3,3'-diindolylmethane decreases activity ISO CYP1A2 (Homo sapiens) 6480464 3 and 3'-diindolylmethane results in decreased activity of CYP1A2 protein CTD PMID:19770484 3,3'-diindolylmethane increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 3 and 3'-diindolylmethane CTD PMID:16544949 3,3'-diindolylmethane multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [3 more ... CTD PMID:16544949 and PMID:19770484 3,4,5,3',4',5'-Hexachlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:15659567 3,4,5,3',4',5'-Hexachlorobiphenyl multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 3 more ... CTD PMID:20961953 3,4,5,3',4',5'-Hexachlorobiphenyl decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 3 more ... CTD PMID:21571617 3,4,5,3',4',5'-Hexachlorobiphenyl decreases activity EXP 6480464 3 more ... CTD PMID:15659567 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases expression ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:23810796 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3 more ... CTD PMID:28160022 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased activity of 3 more ... CTD PMID:2334931 3,4-dichloroaniline increases expression ISO CYP1A2 (Homo sapiens) 6480464 3 more ... CTD PMID:21784029 3,4-dihydroxybenzoic acid multiple interactions EXP 6480464 protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] CTD PMID:15302093 3,4-methylenedioxymethamphetamine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased activity of CYP1A2 protein CTD PMID:24211539 3,5-xylenol increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 3 and 5-xylenol analog CTD PMID:27665777 3,5-xylenol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased oxidation of 3 and 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 3-(Methylthio)-1-propene increases expression EXP 6480464 allyl methyl sulfide results in increased expression of CYP1A2 protein CTD PMID:16000231 3-Amino-1-methyl-5H-pyrido[4,3-b]indole affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole CTD PMID:2655891 3-Amino-1-methyl-5H-pyrido[4,3-b]indole increases expression ISO CYP1A2 (Homo sapiens) 6480464 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole results in increased expression of CYP1A2 mRNA CTD PMID:27644595 3-Amino-1-methyl-5H-pyrido[4,3-b]indole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole CTD PMID:28160022 3-Amino-1-methyl-5H-pyrido[4,3-b]indole increases activity ISO Cyp1a2 (Mus musculus) 6480464 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole results in increased activity of CYP1A2 protein CTD PMID:12744663 3-Amino-1-methyl-5H-pyrido[4,3-b]indole affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole CTD PMID:19140158 3-isobutyl-1-methyl-7H-xanthine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1-Methyl-3-isobutylxanthine results in decreased activity of CYP1A2 protein CTD PMID:11465391 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases activity EXP 6480464 CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4 and 5-f)quinoline CTD PMID:11752233 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-amino-3-methylimidazo(4 and 5-f)quinoline results in increased expression of CYP1A2 mRNA CTD PMID:27644595 and PMID:31542801 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with 2-amino-3-methylimidazo(4 and 5-f)quinoline] results in increased mutagenesis of APRT gene CTD PMID:2023932 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-amino-3-methylimidazo(4 and 5-f)quinoline CTD PMID:2655891 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 2-amino-3-methylimidazo(4 more ... CTD PMID:15728263 and PMID:2334931 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 2-amino-3-methylimidazo(4 and 5-f)quinoline CTD PMID:2023932 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3-methylimidazo(4 more ... CTD PMID:10503888 more ... 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine multiple interactions EXP 6480464 Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4 and 5-f)quinoline] CTD PMID:11752233 3-methylcholanthrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:16639589 and PMID:4054433 3-methylcholanthrene increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 gene mutant form results in increased susceptibility to Methylcholanthrene CTD PMID:32726451 3-methylcholanthrene increases expression ISO CYP1A2 (Homo sapiens) 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA and Methylcholanthrene results in increased expression of CYP1A2 protein CTD PMID:12107646 more ... 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA and Methylcholanthrene results in increased expression of CYP1A2 protein CTD PMID:10476907 more ... 3-methylcholanthrene increases activity EXP 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:15302093 more ... 3-methylcholanthrene increases activity ISO CYP1A2 (Homo sapiens) 6480464 Methylcholanthrene results in increased activity of CYP1A2 protein CTD PMID:19022236 more ... 3-methylcholanthrene multiple interactions EXP 6480464 [[Methylcholanthrene results in increased expression of CYP1A1 protein] co-treated with [Methylcholanthrene results in increased expression of CYP1A2 protein]] results in decreased susceptibility to 3-amino-1 more ... CTD PMID:11999409 more ... 3-methylcholanthrene affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Methylcholanthrene CTD PMID:19772856 3-methylcholanthrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Celsior co-treated with Methylcholanthrene] results in increased expression of CYP1A2 mRNA more ... CTD PMID:15448115 more ... 3-methylcholanthrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CYP1A2 mRNA and Methylcholanthrene results in increased expression of CYP1A2 protein CTD PMID:11356909 more ... 3-methylcholanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Methylcholanthrene binds to and results in increased activity of AHR protein] which results in increased expression of CYP1A2 mRNA more ... CTD PMID:21498875 more ... 3-Methylchrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 3-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 3-methylquinoline decreases activity ISO CYP1A2 (Homo sapiens) 6480464 3-methylquinoline results in decreased activity of CYP1A2 protein CTD PMID:15916432 3-Nitrofluoranthene increases expression ISO CYP1A2 (Homo sapiens) 6480464 3-nitrofluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 3-phenoxybenzoic acid affects binding ISO CYP1A2 (Homo sapiens) 6480464 3-phenoxybenzoic acid binds to CYP1A2 protein CTD PMID:32278787 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of CYP1A2 mRNA CTD PMID:19162173 4',5,7-trihydroxy-3'-methoxyflavone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 chrysoeriol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:20553787 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases activity EXP 6480464 musk ketone results in increased activity of CYP1A2 protein CTD PMID:10630706 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression EXP 6480464 musk ketone results in increased expression of CYP1A2 protein CTD PMID:10630706 4'-tert-Butyl-2',6'-dimethyl-3',5'-dinitroacetophenone increases expression ISO Cyp1a2 (Mus musculus) 6480464 musk ketone results in increased expression of CYP1A2 mRNA CTD PMID:9441723 4,4'-sulfonyldiphenol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 bisphenol S results in decreased activity of CYP1A2 protein CTD PMID:33312107 4-(methylsulfinyl)phenol increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(methylsulfinyl)phenol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased oxidation of 3 and 5-xylenol analog] which results in increased abundance of 4-(methylsulfinyl)phenol analog CTD PMID:27665777 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of and results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:11774366 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:15728263 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-chlorobiphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 4-chlorobiphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 4-Hydroxy-N-desmethyltamoxifen increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of 4-hydroxy-N-desmethyltamoxifen] which results in increased abundance of 4-hydroxy-N-desmethyltamoxifen metabolite CTD PMID:29285606 4-Hydroxybenzyl isothiocyanate multiple interactions EXP 6480464 4-hydroxybenzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 4-Hydroxybenzyl isothiocyanate increases expression EXP 6480464 4-hydroxybenzyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 4-hydroxychalcone affects chemical synthesis EXP 6480464 CYP1A2 protein affects the chemical synthesis of 4-hydroxychalcone CTD PMID:15863696 4-hydroxynon-2-enal multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1 more ... CTD PMID:21766881 4-hydroxyphenyl retinamide increases expression ISO Cyp1a2 (Mus musculus) 6480464 Fenretinide results in increased expression of CYP1A2 mRNA CTD PMID:28973697 4-Ipomeanol increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 4-ipomeanol CTD PMID:15892579 4-Methylchrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 4-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 4-nitroaniline increases activity EXP 6480464 4-nitroaniline analog results in increased activity of CYP1A2 protein CTD PMID:9545601 4-nitroaniline increases expression EXP 6480464 4-nitroaniline analog results in increased expression of CYP1A2 mRNA and 4-nitroaniline analog results in increased expression of CYP1A2 protein CTD PMID:7553614 and PMID:9545601 4-nitrophenol increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of 4-nitrophenol CTD PMID:11911841 4-phenoxyphenol affects binding ISO CYP1A2 (Homo sapiens) 6480464 4-phenoxyphenol binds to CYP1A2 protein CTD PMID:32278787 5,7-dihydroxy-4'-methoxyflavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 acacetin results in decreased activity of CYP1A2 protein CTD PMID:21053930 5,7-dihydroxy-4'-methoxyflavone decreases activity EXP 6480464 acacetin results in decreased activity of CYP1A2 protein CTD PMID:32738202 5-(2-chloroethyl)-4-methylthiazole decreases expression EXP 6480464 Chlormethiazole results in decreased expression of CYP1A2 mRNA CTD PMID:10751552 5-aza-2'-deoxycytidine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Decitabine results in increased expression of CYP1A2 mRNA CTD PMID:30503582 5-aza-2'-deoxycytidine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Decitabine results in increased expression of CYP1A2 mRNA CTD PMID:19274061 and PMID:28357125 5-azacytidine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Azacitidine promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:12927368 5-azacytidine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Azacitidine results in increased expression of CYP1A2 mRNA CTD PMID:12927368 5-Hydroxyflavone increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 5-hydroxyflavone CTD PMID:30964977 5-Hydroxyflavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 5-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP1A2 mRNA and Omeprazole results in increased expression of CYP1A2 protein CTD PMID:12040753 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1A2 mRNA and Omeprazole results in increased expression of CYP1A2 protein CTD PMID:19118567 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA CTD PMID:22687989 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases activity ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in increased activity of CYP1A2 promoter and Omeprazole results in increased activity of CYP1A2 protein CTD PMID:18502397 more ... 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:16035375 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin more ... CTD PMID:15802389 more ... 5-methoxyindole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 5-methoxyindole results in decreased activity of CYP1A2 protein CTD PMID:18420780 5-Methylchrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 5-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 5-methyltryptamine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [5-methyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 5-methyltryptamine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 5-methyltryptamine analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 6-bromoindirubin-3'-oxime increases expression ISO CYP1A2 (Homo sapiens) 6480464 6-bromoindirubin-3'-oxime results in increased expression of CYP1A2 mRNA CTD PMID:26259606 6-bromoindirubin-3'-oxime multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 6-bromoindirubin-3'-oxime results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:26259606 6-chrysenamine increases expression ISO CYP1A2 (Homo sapiens) 6480464 6-chrysenamine results in increased expression of CYP1A2 mRNA CTD PMID:12107646 6-chrysenamine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 6-chrysenamine CTD PMID:15728263 6-Methylchrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 6-methylchrysene results in increased expression of CYP1A2 mRNA CTD PMID:31087746 6-Nitrobenzo[a]pyrene increases expression ISO CYP1A2 (Homo sapiens) 6480464 6-nitrobenzo(a)pyrene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 6-Nitrochrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 6-nitrochrysene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 7,12-dimethyltetraphene increases expression ISO CYP1A2 (Homo sapiens) 6480464 9 more ... CTD PMID:17183067 more ... 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:36863560 7,12-dimethyltetraphene increases activity ISO CYP1A2 (Homo sapiens) 6480464 9 more ... CTD PMID:17183067 7,12-dimethyltetraphene increases activity ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased activity of 9 more ... CTD PMID:15606143 7,12-dimethyltetraphene increases activity EXP 6480464 9 more ... CTD PMID:16054776 7,12-dimethyltetraphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9 more ... CTD PMID:8961944 7,12-dimethyltetraphene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-((2 more ... CTD PMID:17183067 more ... 7-hydroxyflavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 7-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 and PMID:29753067 7-Nitrobenz[a]anthracene increases expression ISO CYP1A2 (Homo sapiens) 6480464 7-nitrobenzanthracene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 7H-Dibenzo[c,g]carbazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of and results in increased activity of 7H-dibenzo(c and g)carbazole CTD PMID:15534862 9-phenanthrol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol CTD PMID:27137136 9-phenanthrol increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of 9-phenanthrol CTD PMID:27137136 acenaphthene increases activity ISO Cyp1a2 (Mus musculus) 6480464 acenaphthene results in increased activity of CYP1A2 protein CTD PMID:8001243 acenaphthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 acenaphthylene increases expression ISO Cyp1a2 (Mus musculus) 6480464 acenaphthylene results in increased expression of CYP1A2 mRNA and acenaphthylene results in increased expression of CYP1A2 protein CTD PMID:8001243 acenaphthylene increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of acenaphthylene CTD PMID:25642975 acenaphthylene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 acenaphthylene increases activity ISO Cyp1a2 (Mus musculus) 6480464 acenaphthylene results in increased activity of CYP1A2 protein CTD PMID:10977129 and PMID:8001243 acenocoumarol affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Acenocoumarol CTD PMID:11918509 acephate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein and [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein CTD PMID:17686559 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP1A2 mRNA CTD PMID:31881176 acetone multiple interactions EXP 6480464 Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] CTD PMID:8996725 acetone increases expression EXP 401900656 acetone increased expression of Cyp1a2 protein in thoracic aorta of rats RGD aconitine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in increased chemical synthesis of Aconitine metabolite CTD PMID:21277363 acridines decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Acridines analog results in decreased activity of CYP1A2 protein CTD PMID:16120190 acridines multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] CTD PMID:16120190 actinomycin D multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [cryptotanshinone results in increased expression of CYP1A2 mRNA] more ... CTD PMID:21262253 Aescin increases expression EXP 401900603 Aescin increased expression of Cyp1a2 mRNA in rat liver RGD Aescin increases activity EXP 401900603 Aescin increased activity of cyp1a2 protein enzyme in rat plasma RGD afimoxifene increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of afimoxifene CTD PMID:29285606 afimoxifene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of afimoxifene] which results in increased abundance of afimoxifene metabolite CTD PMID:29285606 aflatoxin B1 increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of Aflatoxin B1 CTD PMID:15988000 aflatoxin B1 multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of CYP1A2 mRNA] CTD PMID:35063475 aflatoxin B1 decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP1A2 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP1A2 mRNA CTD PMID:26260870 aflatoxin B1 increases expression ISO CYP1A2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CYP1A2 mRNA CTD PMID:21994236 and PMID:32234424 aflatoxin B1 increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Aflatoxin B1 CTD PMID:22743290 and PMID:36442682 aflatoxin B1 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Aflatoxin B1 more ... CTD PMID:20707407 more ... aflatoxin B1 decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of CYP1A2 mRNA CTD PMID:19770486 and PMID:35063475 aflatoxin B1 increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to Aflatoxin B1 CTD PMID:11189750 more ... aflatoxin B1 exo-8,9-epoxide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2 and 3-oxide CTD PMID:20707407 Aflatoxin G1 increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to aflatoxin G1 CTD PMID:11189750 Aflatoxin G1 increases expression ISO CYP1A2 (Homo sapiens) 6480464 aflatoxin G1 results in increased expression of CYP1A2 protein CTD PMID:36997055 aflatoxin M1 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased abundance of Aflatoxin M1 and [CYP1A2 protein results in increased metabolism of Aflatoxin B1] which results in increased chemical synthesis of Aflatoxin M1 CTD PMID:20707407 and PMID:36442682 alachlor increases expression EXP 6480464 alachlor results in increased expression of CYP1A2 protein CTD PMID:11850968 albendazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Albendazole results in increased expression of CYP1A2 mRNA CTD PMID:12451431 albendazole affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Albendazole CTD PMID:12920490 aldehydo-D-glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 alizarin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 alizarin results in decreased activity of CYP1A2 protein CTD PMID:12379470 and PMID:33438235 all-trans-retinoic acid increases expression ISO CYP1A2 (Homo sapiens) 6480464 Tretinoin results in increased expression of CYP1A2 mRNA CTD PMID:16985168 all-trans-retinoic acid decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CYP1A2 mRNA CTD PMID:16882163 and PMID:7697808 all-trans-retinoic acid decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Tretinoin results in decreased activity of CYP1A2 protein CTD PMID:18420780 allocryptopine increases expression ISO CYP1A2 (Homo sapiens) 6480464 allocryptopine results in increased expression of CYP1A2 mRNA CTD PMID:21419197 almotriptan decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of almotriptan CTD PMID:12642466 Aloe emodin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 aloe emodin results in decreased activity of CYP1A2 protein CTD PMID:27633141 and PMID:33438235 alpha-linolenic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 alpha-Linolenic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 alpha-methyltryptamine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [indopan analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin and [indopan results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 alpha-methyltryptamine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 indopan analog results in decreased activity of CYP1A2 protein and indopan results in decreased activity of CYP1A2 protein CTD PMID:26599973 alpha-naphthoflavone increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of alpha-naphthoflavone CTD PMID:17702393 alpha-naphthoflavone affects binding ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein binds to alpha-naphthoflavone CTD PMID:27966929 alpha-naphthoflavone increases expression ISO CYP1A2 (Homo sapiens) 6480464 alpha-naphthoflavone results in increased expression of CYP1A2 mRNA and alpha-naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:19828881 and PMID:28887089 alpha-naphthoflavone affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of alpha-naphthoflavone CTD PMID:2180560 alpha-naphthoflavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 alpha-naphthoflavone results in decreased activity of CYP1A2 protein CTD PMID:15306208 more ... alpha-naphthoflavone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin more ... CTD PMID:18493746 more ... alpha-naphthoflavone increases expression EXP 6480464 alpha-naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:20448087 alpha-naphthoflavone multiple interactions EXP 6480464 [2-amino-3 more ... CTD PMID:18493746 and PMID:20448087 alpha-naphthoflavone multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] and [alpha-naphthoflavone results in decreased activity of CYP1A2 protein] which results in decreased reduction of and results in decreased oxidation of 9-anthraldehyde CTD PMID:21766881 and PMID:21932800 ametryn multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of ametryne] CTD PMID:8971136 ametryn increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of ametryne CTD PMID:8971136 amiodarone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Amiodarone results in decreased activity of CYP1A2 protein CTD PMID:16449812 and PMID:26599973 amiodarone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Amiodarone results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 amiodarone decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amitraz increases expression EXP 6480464 amitraz results in increased expression of CYP1A2 protein CTD PMID:15350676 and PMID:31029719 amitriptyline increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 Amitriptyline results in increased metabolism of CYP1A2 protein and CYP1A2 protein results in increased metabolism of Amitriptyline CTD PMID:18359012 and PMID:27320963 amitriptyline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline CTD PMID:23397584 amitriptylinoxide increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of amitriptyline N-oxide CTD PMID:27320963 amodiaquine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Amodiaquine results in decreased activity of CYP1A2 protein CTD PMID:11124226 amodiaquine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Amodiaquine] which results in increased abundance of desethylamodiaquine more ... CTD PMID:26599973 and PMID:31629065 amodiaquine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Amodiaquine CTD PMID:31629065 amphetamine increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Amphetamine analog CTD PMID:29277574 amphetamine decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of Amphetamine analog CTD PMID:29277574 amphetamine affects chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the chemical synthesis of Amphetamine CTD PMID:15294457 ampicillin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 andrographolide decreases expression ISO CYP1A2 (Homo sapiens) 6480464 andrographolide results in decreased expression of CYP1A2 mRNA CTD PMID:19041297 andrographolide multiple interactions EXP 6480464 andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:20096675 andrographolide increases expression EXP 6480464 andrographolide results in increased expression of CYP1A2 mRNA CTD PMID:19041297 andrographolide increases expression ISO Cyp1a2 (Mus musculus) 6480464 andrographolide results in increased expression of CYP1A2 mRNA CTD PMID:17825862 andrographolide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA and [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA CTD PMID:17825862 and PMID:19737545 angelicin increases expression ISO Cyp1a2 (Mus musculus) 6480464 angelicin results in increased expression of CYP1A2 protein CTD PMID:18692084 aniline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 aniline increases expression EXP 6480464 aniline analog results in increased expression of CYP1A2 mRNA and aniline analog results in increased expression of CYP1A2 protein CTD PMID:16639589 aniline increases activity EXP 6480464 aniline analog results in increased activity of CYP1A2 protein CTD PMID:16639589 anthra[1,9-cd]pyrazol-6(2H)-one increases expression ISO CYP1A2 (Homo sapiens) 6480464 pyrazolanthrone results in increased expression of CYP1A2 mRNA CTD PMID:17959153 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] and resveratrol inhibits the reaction [pyrazolanthrone results in increased expression of CYP1A2 mRNA] CTD PMID:17959153 anthracen-2-amine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYB5A protein promotes the reaction [CYP1A2 protein results in increased activity of 2-anthramine] CTD PMID:15728263 anthracen-2-amine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-anthramine CTD PMID:2655891 anthracen-2-amine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 2-anthramine CTD PMID:15728263 anthracene increases activity ISO Cyp1a2 (Mus musculus) 6480464 anthracene results in increased activity of CYP1A2 protein CTD PMID:8001243 anthracene affects binding ISO CYP1A2 (Homo sapiens) 6480464 anthracene binds to CYP1A2 protein CTD PMID:32278787 anthracene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 anthracene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 alyssin inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] and sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A2 protein] CTD PMID:19362136 anthracene increases activity ISO CYP1A2 (Homo sapiens) 6480464 anthracene results in increased activity of CYP1A2 protein CTD PMID:19362136 anthracene-1,8,9-triol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Anthralin results in decreased activity of CYP1A2 protein CTD PMID:33438235 apigenin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Apigenin results in decreased activity of CYP1A2 protein CTD PMID:20806393 more ... arachidonic acid increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 arachidonic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Arachidonic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 Aranidipine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 aranidipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 arecoline increases activity EXP 6480464 Arecoline analog results in increased activity of CYP1A2 protein CTD PMID:25056785 aristolochic acid A multiple interactions EXP 6480464 [1-phenylazo-2-naphthol co-treated with aristolochic acid I] results in increased expression of CYP1A2 mRNA more ... CTD PMID:26845733 aristolochic acid A increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of aristolochic acid I CTD PMID:26845733 aristolochic acid A increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of aristolochic acid I CTD PMID:21362632 and PMID:26845733 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CYP1A2 mRNA CTD PMID:26845733 aristolochic acid A increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of aristolochic acid I metabolite CTD PMID:22086975 aristolochic acid A multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased oxidation of aristolochic acid I] which results in increased chemical synthesis of aristolochic acid I metabolite more ... CTD PMID:22086975 and PMID:26845733 aristolochic acid A increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of aristolochic acid I CTD PMID:22086975 aristolochic acid A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[alpha-naphthoflavone results in decreased activity of CYP1A2 protein] co-treated with [alpha-naphthoflavone results in decreased activity of CYP1A1 protein]] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] more ... CTD PMID:21932800 aristolochic acid A increases abundance EXP 6480464 CYP1A2 protein results in increased abundance of aristolochic acid I metabolite CTD PMID:21362632 Aroclor 1254 increases activity EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased activity of CYP1A2 protein CTD PMID:11713002 and PMID:8471063 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein CTD PMID:11163329 more ... Aroclor 1254 increases expression ISO CYP1A2 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA and Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 protein CTD PMID:16049271 more ... Aroclor 1254 increases expression ISO Cyp1a2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP1A2 mRNA CTD PMID:25270620 Aroclor 1254 affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 affects the susceptibility to Chlorodiphenyl (54% Chlorine) CTD PMID:19772856 arsenite(3-) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:23369756 arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] more ... CTD PMID:22159698 arsenous acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] and Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] CTD PMID:35872050 arsenous acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] and Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:35872050 Artemisin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 artemisin results in decreased activity of CYP1A2 protein CTD PMID:16261361 asenapine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Asenapine results in decreased activity of CYP1A2 protein CTD PMID:32941854 asenapine decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Asenapine results in decreased expression of CYP1A2 mRNA CTD PMID:32941854 aspartame increases activity EXP 6480464 Aspartame results in increased activity of CYP1A2 protein CTD PMID:16937917 atazanavir sulfate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of CYP1A2 mRNA CTD PMID:33819548 atovaquone increases activity ISO CYP1A2 (Homo sapiens) 6480464 Atovaquone results in increased activity of CYP1A2 protein CTD PMID:11124226 atrazine increases activity EXP 6480464 Atrazine results in increased activity of CYP1A2 protein CTD PMID:9711812 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of CYP1A2 gene CTD PMID:35440735 atrazine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Atrazine results in increased expression of CYP1A2 mRNA CTD PMID:26775023 atrazine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of CYP1A2 mRNA and Lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A2 mRNA] CTD PMID:26775023 and PMID:36216167 atrazine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Atrazine results in increased expression of CYP1A2 mRNA CTD PMID:22310298 atrazine increases activity ISO CYP1A2 (Homo sapiens) 6480464 Atrazine results in increased activity of CYP1A2 protein CTD PMID:22310298 Avasimibe decreases activity ISO CYP1A2 (Homo sapiens) 6480464 avasimibe results in decreased activity of CYP1A2 protein CTD PMID:15333513 azoxystrobin increases expression ISO CYP1A2 (Homo sapiens) 6480464 azoxystrobin results in increased expression of CYP1A2 mRNA and azoxystrobin results in increased expression of CYP1A2 protein CTD PMID:21784029 baicalein increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of baicalein CTD PMID:19666078 baicalein decreases activity ISO CYP1A2 (Homo sapiens) 6480464 baicalein results in decreased activity of CYP1A2 protein CTD PMID:21053930 and PMID:29753067 baicalein multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein CTD PMID:19666078 baicalin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 3' more ... CTD PMID:26204831 baicalin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA] and resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein] CTD PMID:26204831 baicalin increases expression ISO CYP1A2 (Homo sapiens) 6480464 baicalin results in increased expression of CYP1A2 mRNA and baicalin results in increased expression of CYP1A2 protein CTD PMID:26204831 baicalin increases expression ISO Cyp1a2 (Mus musculus) 6480464 baicalin results in increased expression of CYP1A2 mRNA and baicalin results in increased expression of CYP1A2 protein CTD PMID:26204831 benidipine increases expression ISO CYP1A2 (Homo sapiens) 6480464 benidipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 benoxaprofen increases expression EXP 6480464 benoxaprofen results in increased expression of CYP1A2 protein CTD PMID:2069584 benzene decreases expression EXP 6480464 Benzene results in decreased expression of CYP1A2 and Benzene results in decreased expression of CYP1A2 protein CTD PMID:8517779 and PMID:9010585 benzo[a]pyrene increases expression ISO CYP1A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA and Benzo(a)pyrene results in increased expression of CYP1A2 protein CTD PMID:10496959 more ... benzo[a]pyrene decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA CTD PMID:32234424 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA and Benzo(a)pyrene results in increased expression of CYP1A2 protein CTD PMID:16510159 more ... benzo[a]pyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CYP1A2 mRNA and Benzo(a)pyrene results in increased expression of CYP1A2 protein CTD PMID:11171528 more ... benzo[a]pyrene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CYP1A2 mRNA CTD PMID:15034205 benzo[a]pyrene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased activity of CYP1A2 protein CTD PMID:11162773 benzo[a]pyrene increases activity EXP 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 mRNA and Benzo(a)pyrene results in increased activity of CYP1A2 protein CTD PMID:21505853 benzo[a]pyrene increases activity ISO CYP1A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 protein CTD PMID:19202560 benzo[a]pyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased activity of CYP1A2 protein CTD PMID:15863256 and PMID:18321868 benzo[a]pyrene increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Benzo(a)pyrene CTD PMID:2791199 benzo[a]pyrene increases hydrolysis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene CTD PMID:19919601 benzo[a]pyrene affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Benzo(a)pyrene CTD PMID:20542099 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:16510159 more ... benzo[a]pyrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:15034205 more ... benzo[a]pyrene affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Benzo(a)pyrene CTD PMID:16256281 benzo[a]pyrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-oxohexyl isothiocyanate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] more ... CTD PMID:10496959 more ... benzo[b]fluoranthene increases expression ISO Cyp1a2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12117779 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA and [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA CTD PMID:18711122 and PMID:37189300 benzo[b]fluoranthene increases expression ISO CYP1A2 (Homo sapiens) 6480464 benzo(b)fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:16269432 more ... benzo[b]fluoranthene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of CYP1A2 mRNA and [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA CTD PMID:17690111 and PMID:30293151 benzo[b]fluoranthene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 benzo(b)fluoranthene results in decreased activity of CYP1A2 protein CTD PMID:11162773 benzo[b]fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 Benzo[b]fluorene increases expression ISO CYP1A2 (Homo sapiens) 6480464 benzo(b)fluorene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 benzo[c]phenanthrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene and EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] CTD PMID:8961944 benzo[c]phenanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benzo(c)phenanthrene and EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benzo(c)phenanthrene] CTD PMID:8961944 Benzo[k]fluoranthene increases expression ISO CYP1A2 (Homo sapiens) 6480464 benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA and benzo(k)fluoranthene results in increased expression of CYP1A2 protein CTD PMID:11162773 more ... Benzo[k]fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 Benzo[k]fluoranthene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA] and sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 protein] CTD PMID:11162773 Benzo[k]fluoranthene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 benzo(k)fluoranthene results in decreased activity of CYP1A2 protein CTD PMID:11162773 benzofurans decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Benzofurans analog results in decreased activity of CYP1A2 protein CTD PMID:15659567 benzofurans decreases activity EXP 6480464 Benzofurans analog results in decreased activity of CYP1A2 protein CTD PMID:15659567 benzyl isothiocyanate increases expression EXP 6480464 benzyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 benzyl isothiocyanate multiple interactions EXP 6480464 benzyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 benzylideneacetone increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of benzylideneacetone CTD PMID:15863696 berberine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Berberine inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:22342832 bergomottin increases expression ISO Cyp1a2 (Mus musculus) 6480464 bergamottin results in increased expression of CYP1A2 protein CTD PMID:18692084 Besigomsin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrol B results in decreased activity of CYP1A2 protein CTD PMID:25753323 beta-carboline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 beta-carotene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein] and Quercetin inhibits the reaction [beta Carotene promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]] CTD PMID:16970932 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA and beta-Naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:10463385 more ... beta-naphthoflavone increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene mutant form results in increased susceptibility to beta-Naphthoflavone CTD PMID:29180065 beta-naphthoflavone increases activity EXP 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:10463385 more ... beta-naphthoflavone increases activity ISO Cyp1a2 (Mus musculus) 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:21745492 beta-naphthoflavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 beta-naphthoflavone multiple interactions EXP 6480464 [2-amino-3 more ... CTD PMID:18164116 more ... beta-naphthoflavone increases activity ISO CYP1A2 (Homo sapiens) 6480464 beta-Naphthoflavone results in increased activity of CYP1A2 protein CTD PMID:10923861 more ... beta-naphthoflavone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 beta-Naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] more ... CTD PMID:10936227 more ... beta-naphthoflavone increases expression ISO CYP1A2 (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA and beta-Naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:12584154 more ... beta-naphthoflavone multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA more ... CTD PMID:19737545 more ... beta-naphthoflavone increases expression ISO Cyp1a2 (Mus musculus) 6480464 beta-Naphthoflavone results in increased expression of CYP1A2 mRNA and beta-Naphthoflavone results in increased expression of CYP1A2 protein CTD PMID:19737545 more ... bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of CYP1A2 mRNA CTD PMID:16648578 bicalutamide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA] and bicalutamide inhibits the reaction [Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA] CTD PMID:23603339 bilirubin IXalpha decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Bilirubin results in decreased activity of CYP1A2 protein CTD PMID:16183037 bilobalide multiple interactions EXP 6480464 bilobalide results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 bilobalide increases expression EXP 6480464 bilobalide results in increased expression of CYP1A2 mRNA CTD PMID:18421621 binimetinib multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [NADP co-treated with binimetinib] results in decreased activity of CYP1A2 protein CTD PMID:33728909 biochanin A increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of biochanin A CTD PMID:12814970 biochanin A decreases activity EXP 6480464 biochanin A results in decreased activity of CYP1A2 protein CTD PMID:26278343 biochanin A decreases activity ISO CYP1A2 (Homo sapiens) 6480464 biochanin A results in decreased activity of CYP1A2 protein CTD PMID:26278343 biphenyl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 diphenyl results in decreased activity of CYP1A2 protein CTD PMID:15916432 biphenyl increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of diphenyl CTD PMID:27137136 biphenyl-2-ol affects binding ISO CYP1A2 (Homo sapiens) 6480464 2-phenylphenol binds to CYP1A2 protein CTD PMID:32278787 biphenyl-4-amine increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased activity of 4-biphenylamine CTD PMID:15450435 biphenyl-4-amine increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of 4-biphenylamine CTD PMID:2908851 biphenyl-4-amine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 4-biphenylamine and CYP1A2 protein results in increased hydroxylation of and results in increased activity of 4-biphenylamine CTD PMID:16988941 and PMID:23898916 biphenyl-4-amine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of 4-biphenylamine CTD PMID:11376689 biphenyl-4-amine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 4-biphenylamine CTD PMID:2655891 bis(2-ethylhexyl) phthalate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases glutathionylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased glutathionylation of bisphenol A and CYP1A2 protein results in increased glutathionylation of bisphenol A metabolite CTD PMID:23470418 bisphenol A decreases activity ISO CYP1A2 (Homo sapiens) 6480464 bisphenol A results in decreased activity of CYP1A2 protein CTD PMID:33312107 bisphenol A decreases expression ISO Cyp1a2 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP1A2 mRNA CTD PMID:29477810 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP1A2 mRNA CTD PMID:30903817 bisphenol A increases expression ISO Cyp1a2 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP1A2 mRNA CTD PMID:30790712 bisphenol A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Cesium-137 co-treated with bisphenol A] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:28433925 and PMID:29477810 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP1A2 mRNA CTD PMID:25181051 bisphenol A increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of bisphenol A and CYP1A2 protein results in increased hydroxylation of bisphenol A metabolite CTD PMID:23470418 bisphenol F increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 4 and 4'-bisphenol F CTD PMID:23470418 bisphenol F decreases activity ISO CYP1A2 (Homo sapiens) 6480464 bisphenol F results in decreased activity of CYP1A2 protein CTD PMID:33312107 bisphenol F increases glutathionylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased glutathionylation of 4 and 4'-bisphenol F CTD PMID:23470418 bortezomib affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Bortezomib CTD PMID:15764713 bromfenac increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of bromfenac metabolite CTD PMID:31815452 bromodichloromethane increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of bromodichloromethane CTD PMID:12076521 bromodichloromethane increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of bromodichloromethane CTD PMID:11295256 and PMID:12076521 bromodichloromethane multiple interactions EXP 6480464 isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] and Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] CTD PMID:12062927 bromodichloromethane affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of bromodichloromethane CTD PMID:12062927 bromodichloromethane increases expression EXP 6480464 bromodichloromethane results in increased expression of CYP1A2 protein CTD PMID:11295256 bromodichloromethane decreases expression EXP 6480464 bromodichloromethane results in decreased expression of CYP1A2 protein CTD PMID:11295256 brucine multiple interactions EXP 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 bucladesine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Bucladesine affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 Bufuralol increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of bufuralol CTD PMID:9429232 buta-1,3-diene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of CYP1A2 mRNA CTD PMID:29038090 butylated hydroxyanisole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA CTD PMID:25174530 butylated hydroxyanisole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CTNNB1 gene mutant form inhibits the reaction [Butylated Hydroxyanisole results in increased expression of CYP1A2 mRNA] CTD PMID:25174530 Butylbenzyl phthalate decreases activity EXP 6480464 butylbenzyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 Butylparaben decreases activity EXP 6480464 butylparaben results in decreased activity of CYP1A2 protein CTD PMID:27432241 butyric acid increases expression ISO CYP1A2 (Homo sapiens) 6480464 Butyric Acid results in increased expression of CYP1A2 mRNA CTD PMID:30439556 butyric acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Benzo(a)pyrene promotes the reaction [Butyric Acid results in increased expression of CYP1A2 mRNA] and Butyric Acid promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:30439556 C.I. Natural Red 20 decreases activity EXP 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 C.I. Natural Red 20 decreases activity ISO CYP1A2 (Homo sapiens) 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CYP1A2 mRNA CTD PMID:19167457 cadmium dichloride decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased activity of CYP1A2 protein CTD PMID:11162773 caffeine affects binding ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein binds to Caffeine CTD PMID:9334905 caffeine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 caffeine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Caffeine CTD PMID:11907490 more ... caffeine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased chemical synthesis of 1 more ... CTD PMID:11145498 more ... caffeine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Caffeine results in decreased activity of CYP1A2 protein CTD PMID:11465391 and PMID:24211539 caffeine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Caffeine results in decreased activity of CYP1A2 protein CTD PMID:18420780 caffeine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Caffeine and CYP1A2 protein affects the metabolism of Caffeine metabolite CTD PMID:1302044 more ... caffeine multiple interactions EXP 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine more ... CTD PMID:12706856 more ... caffeine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Caffeine CTD PMID:15619608 caffeine increases activity EXP 6480464 Caffeine results in increased activity of CYP1A2 protein CTD PMID:15822860 caffeine decreases methylation ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in decreased methylation of Caffeine CTD PMID:11376689 caffeine decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of Caffeine CTD PMID:11145498 and PMID:12433797 canadine increases expression ISO Cyp1a2 (Mus musculus) 6480464 canadine results in increased expression of CYP1A2 mRNA and canadine results in increased expression of CYP1A2 protein CTD PMID:28257954 cannabidiol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Cannabidiol results in decreased activity of CYP1A2 protein CTD PMID:24667653 cannabidiol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Cannabidiol results in increased expression of CYP1A2 mRNA CTD PMID:31052254 cannabidiol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Plant Extracts results in increased abundance of Cannabidiol] which results in increased expression of CYP1A2 mRNA CTD PMID:33096940 canthaxanthin increases expression EXP 6480464 Canthaxanthin results in increased expression of CYP1A2 mRNA CTD PMID:9271336 canthaxanthin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Canthaxanthin results in increased expression of CYP1A2 mRNA CTD PMID:9271336 capsaicin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Capsaicin results in decreased activity of CYP1A2 protein CTD PMID:22375877 carbamazepine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP1A2 mRNA CTD PMID:17112801 carbamazepine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine CTD PMID:23397584 carbamazepine decreases expression EXP 6480464 Carbamazepine results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 carbaryl multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Carbaryl inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] and Carbaryl inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] CTD PMID:16790556 carbaryl increases expression EXP 6480464 Carbaryl results in increased expression of CYP1A2 protein CTD PMID:9858662 carbaryl decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Carbaryl results in decreased activity of CYP1A2 protein CTD PMID:16790556 carbendazim increases expression ISO CYP1A2 (Homo sapiens) 6480464 carbendazim results in increased expression of CYP1A2 mRNA and carbendazim results in increased expression of CYP1A2 protein CTD PMID:21784029 carbofuran increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Carbofuran CTD PMID:15560889 carbon nanotube decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Carnosol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 carnosol results in decreased activity of CYP1A2 protein CTD PMID:34592323 carotenoid affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein polymorphism affects the susceptibility to Carotenoids CTD PMID:15095308 caryophyllene oxide decreases activity ISO CYP1A2 (Homo sapiens) 6480464 caryophyllene oxide results in decreased activity of CYP1A2 protein CTD PMID:29074051 caryophyllene oxide decreases activity EXP 6480464 caryophyllene oxide results in decreased activity of CYP1A2 protein CTD PMID:29074051 catechols multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased hydroxylation of zearalenol] which results in increased chemical synthesis of Catechols and [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols CTD PMID:19931366 celecoxib decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Celecoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 CGP 52608 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CYP1A2 gene] CTD PMID:28238834 chalcone increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 chelidonine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of chelidonine CTD PMID:31102647 chelidonine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of chelidonine] which results in increased abundance of Glutathione analog CTD PMID:31102647 chenodeoxycholic acid decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:27174168 chenodeoxycholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33819548 CHIR 99021 increases expression ISO CYP1A2 (Homo sapiens) 6480464 Chir 99021 results in increased expression of CYP1A2 mRNA CTD PMID:26259606 CHIR 99021 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Chir 99021 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:34403729 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP1A2 mRNA CTD PMID:30744511 chloroquine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Chloroquine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine] CTD PMID:7946932 chlorotoluron decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased susceptibility to chlortoluron CTD PMID:24920432 chlorpromazine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Chlorpromazine co-treated with Cholic Acids] affects the expression of CYP1A2 mRNA more ... CTD PMID:18493746 more ... chlorpromazine decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of CYP1A2 mRNA CTD PMID:25596134 chlorpromazine increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of Chlorpromazine CTD PMID:20615392 chlorpromazine affects expression EXP 6480464 Chlorpromazine affects the expression of CYP1A2 mRNA CTD PMID:18246545 chlorpromazine decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of Chlorpromazine CTD PMID:20615392 chlorpyrifos multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] and Chlorpyrifos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] CTD PMID:16790556 chlorpyrifos increases expression ISO Cyp1a2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CYP1A2 mRNA CTD PMID:29097212 chlorpyrifos multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats results in increased susceptibility to Chlorpyrifos] which results in decreased expression of CYP1A2 mRNA and Chlorpyrifos inhibits the reaction [Dietary Fats results in decreased expression of CYP1A2 mRNA] CTD PMID:29097212 and PMID:29935250 chlorpyrifos decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Chlorpyrifos results in decreased activity of CYP1A2 protein CTD PMID:16790556 more ... chlorpyrifos increases expression ISO CYP1A2 (Homo sapiens) 6480464 Chlorpyrifos results in increased expression of CYP1A2 mRNA CTD PMID:16190164 more ... chlorpyrifos affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Chlorpyrifos CTD PMID:15557345 and PMID:17079358 chlorpyrifos decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Chlorpyrifos results in decreased expression of CYP1A2 protein CTD PMID:21784029 chlorzoxazone affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Chlorzoxazone CTD PMID:14586387 chlorzoxazone affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Chlorzoxazone CTD PMID:15879494 chlorzoxazone increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Chlorzoxazone CTD PMID:11911841 choline multiple interactions EXP 6480464 Choline deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 protein] and Choline deficiency promotes the reaction [Phenobarbital results in increased expression of CYP1A2 protein] CTD PMID:18798224 choline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [3 more ... CTD PMID:27712037 more ... chromium(6+) increases expression ISO CYP1A2 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of CYP1A2 protein CTD PMID:36368423 chromium(6+) multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [chromium hexavalent ion results in increased expression of CYP1A2 protein] and AHR protein affects the reaction [chromium hexavalent ion results in increased expression of CYP1A2 protein] CTD PMID:36368423 chrysazin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 danthron results in decreased activity of CYP1A2 protein CTD PMID:33438235 chrysene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene and EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of chrysene] CTD PMID:8961944 chrysene multiple interactions EXP 6480464 [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA more ... CTD PMID:37189300 chrysene increases expression ISO CYP1A2 (Homo sapiens) 6480464 chrysene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 more ... chrysene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of chrysene more ... CTD PMID:7750161 and PMID:8961944 chrysin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of chrysin CTD PMID:19666078 chrysin increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of chrysin CTD PMID:30964977 chrysin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein CTD PMID:19666078 chrysin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 chrysin results in decreased activity of CYP1A2 protein CTD PMID:20806393 and PMID:21053930 chrysophanol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 chrysophanic acid results in decreased activity of CYP1A2 protein CTD PMID:27633141 and PMID:33438235 chrysophanol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of chrysophanic acid] which results in increased chemical synthesis of 2-hydroxychrysophanol CTD PMID:29698620 chrysophanol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of chrysophanic acid CTD PMID:29698620 ciglitazone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA and [ciglitazone binds to PPARG protein] which results in increased expression of CYP1A2 mRNA CTD PMID:16197558 cimetidine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Cimetidine results in decreased activity of CYP1A2 protein CTD PMID:19909766 and PMID:31863871 cimetidine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Cimetidine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine] more ... CTD PMID:19909766 and PMID:7946932 ciprofibrate decreases expression EXP 6480464 ciprofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:7676460 ciprofibrate decreases expression ISO Cyp1a2 (Mus musculus) 6480464 ciprofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:17962186 ciprofibrate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 ciprofibrate inhibits the reaction [Phenobarbital results in increased expression of CYP1A2 mRNA] CTD PMID:17962186 ciprofloxacin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine more ... CTD PMID:11145498 more ... ciprofloxacin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Ciprofloxacin results in decreased activity of CYP1A2 protein CTD PMID:11145498 more ... cisplatin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 cisplatin multiple interactions EXP 6480464 Cisplatin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 clarithromycin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:11408986 clenbuterol multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] and Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] CTD PMID:15710352 clodronic acid increases expression ISO CYP1A2 (Homo sapiens) 6480464 Clodronic Acid results in increased expression of CYP1A2 mRNA CTD PMID:25596134 clofibrate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CYP1A2 mRNA and Clofibrate results in decreased expression of CYP1A2 protein CTD PMID:11328961 more ... clofibrate decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Clofibrate results in decreased expression of CYP1A2 mRNA CTD PMID:17585979 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of CYP1A2 mRNA CTD PMID:17602206 clopidogrel multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of and results in increased cleavage of Clopidogrel metabolite and furafylline inhibits the reaction [CYP1A2 protein results in increased oxidation of Clopidogrel] CTD PMID:19170597 and PMID:19812348 clopidogrel increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of clopidogrel CTD PMID:19812348 clothianidin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA and [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA CTD PMID:32201337 clothianidin increases expression ISO CYP1A2 (Homo sapiens) 6480464 clothianidin results in increased expression of CYP1A2 mRNA CTD PMID:32201337 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of CYP1A2 protein CTD PMID:7986207 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 clozapine affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP affects the susceptibility to Clozapine and CYP1A2 protein affects the susceptibility to Clozapine CTD PMID:12919186 and PMID:15206669 clozapine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP results in increased metabolism of Clozapine and CYP1A2 protein results in increased metabolism of Clozapine CTD PMID:11763009 more ... clozapine decreases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP results in decreased metabolism of Clozapine CTD PMID:12919186 clozapine decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP results in decreased susceptibility to Clozapine CTD PMID:11763009 clozapine multiple interactions EXP 6480464 Clozapine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 clozapine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Clozapine CTD PMID:12969762 clozapine increases expression ISO Cyp1a2 (Mus musculus) 6480464 Clozapine results in increased expression of CYP1A2 mRNA CTD PMID:12969762 clozapine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene polymorphism affects the metabolism of Clozapine more ... CTD PMID:15286053 more ... clozapine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of Clozapine more ... CTD PMID:11151749 more ... Clozapine N-oxide increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of clozapine N-oxide CTD PMID:27320963 Clozapine N-oxide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide] CTD PMID:18809730 Clozapine N-oxide increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of clozapine N-oxide CTD PMID:18809730 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP1A2 mRNA CTD PMID:24386269 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] CTD PMID:15710352 colforsin daropate hydrochloride multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Colforsin affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 copper atom multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 copper(0) multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 copper(II) sulfate decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CYP1A2 mRNA CTD PMID:19549813 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [Ethanol results in increased expression of CYP1A2 mRNA] CTD PMID:35301062 corticosterone increases expression ISO CYP1A2 (Homo sapiens) 6480464 Corticosterone results in increased expression of CYP1A2 mRNA CTD PMID:35301062 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CYP1A2 mRNA CTD PMID:35301062 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of CYP1A2 mRNA CTD PMID:18480146 coumarin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 2-hydroxyphenylacetic acid and [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 7-hydroxycoumarin CTD PMID:34334558 coumarin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of coumarin CTD PMID:34334558 coumarin affects expression EXP 6480464 coumarin affects the expression of CYP1A2 mRNA CTD PMID:16963487 Cryptotanshinone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 cryptotanshinone promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] more ... CTD PMID:21262253 Cryptotanshinone increases expression ISO CYP1A2 (Homo sapiens) 6480464 cryptotanshinone results in increased expression of CYP1A2 mRNA and cryptotanshinone results in increased expression of CYP1A2 protein CTD PMID:21262253 curcumin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Curcumin results in decreased activity of CYP1A2 protein CTD PMID:15841493 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP1A2 protein] and Curcumin inhibits the reaction [Fenitrothion results in increased expression of CYP1A2 mRNA] CTD PMID:16288784 and PMID:34802538 curcumin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of CYP1A2 mRNA] more ... CTD PMID:18321868 and PMID:35063475 cyclobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyclobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 cycloheximide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Cycloheximide affects the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:1849469 cyclophosphamide decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Cyclophosphamide results in decreased activity of CYP1A2 protein CTD PMID:18420780 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 cyclosporin A multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of CYP1A2 mRNA CTD PMID:33819548 cyhalothrin increases activity ISO CYP1A2 (Homo sapiens) 6480464 cyhalothrin results in increased activity of CYP1A2 protein CTD PMID:22310298 cyhalothrin increases activity EXP 6480464 cyhalothrin results in increased activity of CYP1A2 protein CTD PMID:29727961 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP1A2 mRNA CTD PMID:29727961 cylindrospermopsin increases expression ISO CYP1A2 (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of CYP1A2 mRNA CTD PMID:21607682 cylindrospermopsin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of CYP1A2 mRNA CTD PMID:20936652 cypermethrin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 cypermethrin results in decreased activity of CYP1A2 protein CTD PMID:18420780 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CYP1A2 mRNA CTD PMID:23447098 and PMID:26115703 cyproconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyproconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 and PMID:25656644 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP1A2 protein CTD PMID:33150952 cyproconazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 cyproconazole results in increased expression of CYP1A2 mRNA and cyproconazole results in increased expression of CYP1A2 protein CTD PMID:29995386 and PMID:33150952 cyproconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 promotes the reaction [cyproconazole results in increased expression of CYP1A2 mRNA] CTD PMID:25656644 D-glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 dabrafenib decreases activity ISO CYP1A2 (Homo sapiens) 6480464 dabrafenib results in decreased activity of CYP1A2 protein CTD PMID:34780725 dacarbazine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Dacarbazine metabolite CTD PMID:11751525 dacarbazine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 O(6)-benzylguanine inhibits the reaction [CYP1A2 protein results in increased metabolism of Dacarbazine metabolite] CTD PMID:11751525 daidzein decreases activity ISO Cyp1a2 (Mus musculus) 6480464 daidzein results in decreased activity of CYP1A2 protein CTD PMID:18420780 dantrolene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Dantrolene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 DDT increases expression EXP 6480464 DDT results in increased expression of CYP1A2 mRNA CTD PMID:29477483 decabromodiphenyl ether increases activity EXP 6480464 decabromobiphenyl ether results in increased activity of CYP1A2 protein CTD PMID:18495385 decabromodiphenyl ether increases expression ISO CYP1A2 (Homo sapiens) 6480464 decabromobiphenyl ether results in increased expression of CYP1A2 mRNA CTD PMID:19270788 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of CYP1A2 mRNA and decabromobiphenyl ether results in increased expression of CYP1A2 protein CTD PMID:18495385 more ... dehydroepiandrosterone decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA CTD PMID:23603339 dehydroepiandrosterone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [bicalutamide binds to and results in decreased activity of AR protein] inhibits the reaction [Dehydroepiandrosterone results in decreased expression of CYP1A2 mRNA] more ... CTD PMID:23603339 dehydroepiandrosterone increases degradation ISO CYP1A2 (Homo sapiens) 6480464 Dehydroepiandrosterone results in increased degradation of CYP1A2 mRNA CTD PMID:23603339 deoxycholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33819548 Deoxyschizandrin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrin A results in decreased activity of CYP1A2 protein CTD PMID:25753323 desogestrel decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Desogestrel results in decreased activity of CYP1A2 protein CTD PMID:18816299 dexamethasone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] more ... CTD PMID:19022236 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CYP1A2 mRNA CTD PMID:11328961 more ... dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CYP1A2 mRNA CTD PMID:15607757 dexamethasone multiple interactions EXP 6480464 Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] and Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] CTD PMID:17690134 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of CYP1A2 mRNA CTD PMID:15102944 dexamethasone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Dexamethasone results in decreased activity of CYP1A2 protein CTD PMID:19022236 dexamethasone decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of CYP1A2 protein CTD PMID:19022236 dexmedetomidine multiple interactions EXP 6480464 atipamezole inhibits the reaction [Dexmedetomidine promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein]] more ... CTD PMID:16510159 dextran sulfate multiple interactions EXP 6480464 [Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of Acetaminophen CTD PMID:28438436 dextran sulfate decreases activity EXP 6480464 Dextran Sulfate results in decreased activity of CYP1A2 protein CTD PMID:28438436 dextromethorphan affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Dextromethorphan CTD PMID:15199075 diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of CYP1A2 protein CTD PMID:16000231 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of and results in decreased activity of CYP1A2 protein] and allyl sulfide inhibits the reaction [Diethylnitrosamine results in decreased expression of CYP1A2 mRNA] CTD PMID:23494807 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of CYP1A2 mRNA CTD PMID:19695238 and PMID:8849338 diallyl trisulfide multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein] CTD PMID:28115069 diarsenic trioxide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] and Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein] CTD PMID:35872050 diarsenic trioxide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] and Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:35872050 diarylheptanoid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Diarylheptanoids results in decreased activity of CYP1A2 protein CTD PMID:23850985 diazinon multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased sulfation of and results in increased activity of Diazinon and CYP1A2 protein results in increased metabolism of and results in increased activity of Diazinon CTD PMID:11708902 and PMID:15764407 diazinon affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Diazinon CTD PMID:15557345 and PMID:15764407 diazinon multiple interactions EXP 6480464 [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon CTD PMID:17442507 diazinon increases expression ISO CYP1A2 (Homo sapiens) 6480464 Diazinon results in increased expression of CYP1A2 mRNA and Diazinon results in increased expression of CYP1A2 protein CTD PMID:21784029 Dibenz[a,c]anthracene increases expression ISO CYP1A2 (Homo sapiens) 6480464 benzotriphenylene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 dibenz[a,h]anthracene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 more ... dibenz[a,h]anthracene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 dibenz[a,h]anthracene increases expression ISO CYP1A2 (Homo sapiens) 6480464 1 more ... CTD PMID:16269432 and PMID:17253728 dibenz[a,h]anthracene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1 more ... CTD PMID:11162773 dibenz[a,h]anthracene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 1 more ... CTD PMID:8961944 dibenz[a,h]anthracene increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 1 more ... CTD PMID:8638931 dibenz[a,h]anthracene increases activity ISO CYP1A2 (Homo sapiens) 6480464 1 more ... CTD PMID:19362136 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [beta-Naphthoflavone results in increased activity of CYP1A2 protein] CTD PMID:26880746 dibenziodolium decreases activity EXP 6480464 diphenyleneiodonium results in decreased activity of CYP1A2 protein CTD PMID:26880746 dibenzo[a,l]pyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased activity of dibenzo(a and l)pyrene CTD PMID:15606143 dibenzo[a,l]pyrene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 dibenzo[a,l]pyrene increases expression ISO CYP1A2 (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in increased expression of CYP1A2 mRNA CTD PMID:16269432 dibenzo[a,l]pyrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Benzo(a)pyrene co-treated with dibenzo(a and l)pyrene] affects the expression of CYP1A2 mRNA CTD PMID:17690111 dibenzofuran increases activity ISO Cyp1a2 (Mus musculus) 6480464 dibenzofuran results in increased activity of CYP1A2 protein CTD PMID:8001243 dibenzofuran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 dibenzofuran increases activity ISO CYP1A2 (Homo sapiens) 6480464 dibenzofuran metabolite results in increased activity of CYP1A2 protein CTD PMID:26032510 dibenzofurans increases expression ISO Cyp1a2 (Mus musculus) 6480464 Dibenzofurans results in increased expression of CYP1A2 mRNA CTD PMID:34254344 dibutyl phthalate decreases activity EXP 6480464 Dibutyl Phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 dichloroacetic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:28962523 dichloromethane affects expression ISO Cyp1a2 (Mus musculus) 6480464 Methylene Chloride affects the expression of CYP1A2 mRNA CTD PMID:28392392 diclofenac increases expression ISO CYP1A2 (Homo sapiens) 6480464 Diclofenac results in increased expression of CYP1A2 mRNA and Diclofenac results in increased expression of CYP1A2 protein CTD PMID:21784029 diclofenac decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Diclofenac metabolite results in decreased activity of CYP1A2 protein CTD PMID:28960974 diclofenac multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac CTD PMID:23397584 dicofol increases expression EXP 6480464 Dicofol results in increased expression of CYP1A2 mRNA CTD PMID:19595748 dicrotophos increases expression ISO CYP1A2 (Homo sapiens) 6480464 dicrotophos results in increased expression of CYP1A2 mRNA CTD PMID:28302478 Dicyclohexyl phthalate decreases activity EXP 6480464 dicyclohexyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of CYP1A2 mRNA CTD PMID:10910964 diethyl phthalate decreases activity EXP 6480464 diethyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 diethyldithiocarbamic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 diethyldithiocarbamic acid multiple interactions EXP 6480464 Ditiocarb inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 diethylstilbestrol affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the susceptibility to Diethylstilbestrol CTD PMID:8242868 difenoconazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 difenoconazole results in increased expression of CYP1A2 mRNA CTD PMID:33575850 difenoconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 difenoconazole results in increased expression of CYP1A2 mRNA CTD PMID:34425431 difenoconazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA CTD PMID:33575850 diflubenzuron affects binding ISO CYP1A2 (Homo sapiens) 6480464 Diflubenzuron binds to CYP1A2 protein CTD PMID:32278787 dihydroartemisinin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 artenimol results in decreased activity of CYP1A2 protein CTD PMID:11124226 dihydrocapsaicin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 dihydrocapsaicin results in decreased activity of CYP1A2 protein CTD PMID:22375877 Dihydrotanshinone I multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [dihydrotanshinone I results in increased expression of CYP1A2 mRNA] more ... CTD PMID:21262253 Dihydrotanshinone I increases expression ISO CYP1A2 (Homo sapiens) 6480464 dihydrotanshinone I results in increased expression of CYP1A2 mRNA and dihydrotanshinone I results in increased expression of CYP1A2 protein CTD PMID:21262253 dimethocaine increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of dimethocaine CTD PMID:24309420 Dimethyl phthalate decreases activity EXP 6480464 dimethyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 dimethyl sulfoxide affects expression ISO CYP1A2 (Homo sapiens) 6480464 Dimethyl Sulfoxide affects the expression of CYP1A2 mRNA CTD PMID:12843640 dimethyl sulfoxide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Dimethyl Sulfoxide results in increased expression of CYP1A2 mRNA CTD PMID:30262279 dimethyl sulfoxide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Dimethyl Sulfoxide co-treated with TGFB1 protein] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:18347083 and PMID:35366062 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of CYP1A2 mRNA CTD PMID:17481689 dimethylmercury decreases expression EXP 6480464 dimethyl mercury results in decreased expression of CYP1A2 protein CTD PMID:21424224 dimethylmercury multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] CTD PMID:21424224 diosmetin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 diosmetin results in decreased activity of CYP1A2 protein CTD PMID:28867436 diosmetin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin CTD PMID:33727136 diosmetin increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to diosmetin CTD PMID:33727136 dioxygen decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of CYP1A2 mRNA CTD PMID:19695866 dioxygen increases expression ISO CYP1A2 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of CYP1A2 mRNA CTD PMID:33811995 dioxygen increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene mutant form results in increased susceptibility to Oxygen CTD PMID:29180065 dioxygen increases expression ISO Cyp1a2 (Mus musculus) 6480464 Oxygen results in increased expression of CYP1A2 mRNA CTD PMID:25703676 dioxygen multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression of NQO1 mRNA more ... CTD PMID:26845733 more ... dioxygen multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein more ... CTD PMID:24657529 more ... dioxygen increases activity ISO Cyp1a2 (Mus musculus) 6480464 Oxygen results in increased activity of CYP1A2 protein CTD PMID:21745492 dioxygen multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen] more ... CTD PMID:21745492 more ... dipropyl phthalate decreases activity EXP 6480464 di-n-propylphthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 diuron increases expression ISO CYP1A2 (Homo sapiens) 6480464 Diuron results in increased expression of CYP1A2 mRNA and Diuron results in increased expression of CYP1A2 protein CTD PMID:21784029 and PMID:22310298 domperidone increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 dopamine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Dopamine results in decreased activity of CYP1A2 protein CTD PMID:18420780 doxorubicin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 doxorubicin multiple interactions EXP 6480464 Doxorubicin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 elemental selenium multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] CTD PMID:21424224 Elemicin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of elemicin CTD PMID:31468958 Elemicin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of elemicin] which results in increased abundance of elemicin metabolite CTD PMID:31468958 ellipticine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of ellipticine CTD PMID:22917556 ellipticine multiple interactions EXP 6480464 ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 ellipticine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 ellipticine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 emodin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CTD PMID:27989148 emodin increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Emodin CTD PMID:30672276 emodin increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of Emodin CTD PMID:27989148 emodin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Emodin results in decreased activity of CYP1A2 protein CTD PMID:27633141 and PMID:33438235 endosulfan increases expression ISO Cyp1a2 (Mus musculus) 6480464 Endosulfan analog results in increased expression of CYP1A2 mRNA and Endosulfan results in increased expression of CYP1A2 mRNA CTD PMID:29702342 enfuvirtide affects activity ISO CYP1A2 (Homo sapiens) 6480464 enfuvirtide affects the activity of CYP1A2 protein CTD PMID:15656696 enilconazole affects expression ISO CYP1A2 (Homo sapiens) 6480464 enilconazole affects the expression of CYP1A2 mRNA CTD PMID:32201337 enilconazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [clothianidin co-treated with enilconazole] results in increased expression of CYP1A2 mRNA more ... CTD PMID:32201337 enoxacin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Enoxacin inhibits the reaction [CYP1A2 protein affects the metabolism of Fluvoxamine] more ... CTD PMID:15905806 and PMID:7946932 enoxacin multiple interactions EXP 6480464 Enoxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:8905919 enoxacin affects binding EXP 6480464 Enoxacin binds to CYP1A2 protein CTD PMID:8905919 enoxacin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Enoxacin results in decreased activity of CYP1A2 protein CTD PMID:15905806 epoxiconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 epoxiconazole results in increased expression of CYP1A2 mRNA CTD PMID:22334560 Erucin increases expression EXP 6480464 erucin results in increased expression of CYP1A2 protein CTD PMID:20833222 estragole increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of estragole CTD PMID:19920071 estragole increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to estragole CTD PMID:32853702 estragole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with estragole] results in increased expression of CYP1A2 mRNA CTD PMID:31029721 estragole increases expression ISO Cyp1a2 (Mus musculus) 6480464 estragole results in increased expression of CYP1A2 mRNA CTD PMID:31029721 estrone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein promotes the reaction [Estrone binds to Deoxyguanosine] CTD PMID:21907773 estrone affects binding ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein binds to Estrone CTD PMID:27966929 ethambutol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Ethambutol results in decreased activity of CYP1A2 protein CTD PMID:24910189 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP1A2 mRNA and Ethanol results in increased expression of CYP1A2 protein CTD PMID:23273579 more ... ethanol increases expression ISO CYP1A2 (Homo sapiens) 6480464 Ethanol results in increased expression of CYP1A2 mRNA CTD PMID:35301062 ethanol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP1A2 mRNA CTD PMID:30517762 ethanol multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein more ... CTD PMID:26747958 and PMID:35301062 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of CYP1A2 mRNA CTD PMID:19695238 ethylisopropylamiloride decreases activity ISO CYP1A2 (Homo sapiens) 6480464 ethylisopropylamiloride results in decreased activity of CYP1A2 protein CTD PMID:15081870 ethylparaben decreases activity EXP 6480464 ethyl-p-hydroxybenzoate results in decreased activity of CYP1A2 protein CTD PMID:27432241 etodolac decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Etodolac results in decreased activity of CYP1A2 protein CTD PMID:18816299 etoposide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Etoposide results in increased expression of CYP1A2 mRNA CTD PMID:31542801 etoricoxib decreases activity ISO CYP1A2 (Homo sapiens) 6480464 etoricoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 eugenol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol CTD PMID:15576237 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP1A2 protein CTD PMID:15840382 farnesol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP1A2 mRNA] CTD PMID:30611723 farrerol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 farrerol results in decreased activity of CYP1A2 protein CTD PMID:29753067 felbamate decreases expression EXP 6480464 felbamate results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 felodipine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Felodipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 fenarimol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with acephate] affects the expression of CYP1A2 protein more ... CTD PMID:17686559 fenbendazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Fenbendazole results in decreased activity of CYP1A2 protein CTD PMID:22048645 fenitrothion increases expression ISO CYP1A2 (Homo sapiens) 6480464 Fenitrothion results in increased expression of CYP1A2 mRNA CTD PMID:22310298 fenitrothion increases expression EXP 6480464 Fenitrothion results in increased expression of CYP1A2 mRNA CTD PMID:34802538 fenitrothion multiple interactions EXP 6480464 Curcumin inhibits the reaction [Fenitrothion results in increased expression of CYP1A2 mRNA] CTD PMID:34802538 fenitrothion decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Fenitrothion results in decreased activity of CYP1A2 protein CTD PMID:20183062 and PMID:22634058 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP1A2 mRNA CTD PMID:18253720 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of CYP1A2 mRNA CTD PMID:20801182 and PMID:25596134 fenproporex decreases alkylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased alkylation of fenproporex CTD PMID:15294457 fenvalerate increases activity ISO CYP1A2 (Homo sapiens) 6480464 fenvalerate results in increased activity of CYP1A2 protein CTD PMID:22310298 ferulic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 ferulic acid results in decreased activity of CYP1A2 protein CTD PMID:15841493 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 fipronil multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA CTD PMID:27091632 flavanone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 flavanone results in decreased activity of CYP1A2 protein CTD PMID:21053930 flavone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 flavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 flavone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 flavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 flavonol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 3-hydroxyflavone results in decreased activity of CYP1A2 protein CTD PMID:21053930 and PMID:29753067 fluconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Fluconazole results in increased expression of CYP1A2 mRNA CTD PMID:16730040 fludioxonil increases expression ISO CYP1A2 (Homo sapiens) 6480464 fludioxonil results in increased expression of CYP1A2 mRNA CTD PMID:33575850 fludioxonil multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [difenoconazole co-treated with fludioxonil] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33575850 flumequine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 and PMID:31029721 fluoranthene increases expression ISO CYP1A2 (Homo sapiens) 6480464 fluoranthene results in increased expression of CYP1A2 mRNA CTD PMID:12107646 and PMID:21784029 fluoranthene multiple interactions EXP 6480464 [1 more ... CTD PMID:18711122 fluoranthene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 fluorene increases activity ISO Cyp1a2 (Mus musculus) 6480464 fluorene results in increased activity of CYP1A2 protein CTD PMID:8001243 fluorene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:7750161 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CYP1A2 mRNA CTD PMID:24136188 and PMID:26485406 flutamide increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to Flutamide CTD PMID:28762043 flutamide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Flutamide CTD PMID:23397584 fluvoxamine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine metabolite more ... CTD PMID:15545309 more ... fluvoxamine decreases activity EXP 6480464 Fluvoxamine results in decreased activity of CYP1A2 protein CTD PMID:26599973 fluvoxamine multiple interactions EXP 6480464 [Fluvoxamine results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Caffeine CTD PMID:26599973 fluvoxamine increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to Fluvoxamine CTD PMID:18809730 fluvoxamine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Fluvoxamine results in decreased activity of CYP1A2 protein CTD PMID:11763009 more ... folic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of CYP1A2 mRNA CTD PMID:29127188 fonofos multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Fonofos inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] and Fonofos inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] CTD PMID:16790556 fonofos decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Fonofos results in decreased activity of CYP1A2 protein CTD PMID:16790556 formononetin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 formononetin results in decreased activity of CYP1A2 protein CTD PMID:26278343 formononetin decreases activity EXP 6480464 formononetin results in decreased activity of CYP1A2 protein CTD PMID:26278343 Frangulin A multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein CTD PMID:33438235 Frangulin B multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [frangulin A co-treated with frangulin B] results in decreased activity of CYP1A2 protein CTD PMID:33438235 fructose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA more ... CTD PMID:26102010 Furafylline decreases activity EXP 6480464 furafylline results in decreased activity of CYP1A2 protein CTD PMID:12814958 and PMID:15879494 Furafylline decreases activity ISO CYP1A2 (Homo sapiens) 6480464 furafylline results in decreased activity of CYP1A2 protein CTD PMID:12467917 more ... Furafylline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased susceptibility to 2-amino-9H-pyrido(2 more ... CTD PMID:10215755 more ... Furafylline multiple interactions EXP 6480464 [furafylline results in decreased activity of CYP1A2 protein] which results in decreased glutathionylation of Duloxetine Hydrochloride and furafylline inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 and PMID:20669986 Furafylline multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [furafylline results in decreased activity of CYP1A2 protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]] more ... CTD PMID:21932800 and PMID:22491429 furan decreases expression EXP 6480464 furan results in decreased expression of CYP1A2 mRNA CTD PMID:25539665 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] CTD PMID:18202523 galangin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 galangin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 galangin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 galangin results in decreased activity of CYP1A2 protein CTD PMID:20806393 and PMID:21053930 gallocatechin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA CTD PMID:25663641 gamma-decalactone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 decan-4-olide results in decreased activity of CYP1A2 protein CTD PMID:15916432 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of CYP1A2 protein CTD PMID:12842176 and PMID:16641539 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Hexachlorocyclohexane results in increased expression of and results in increased activity of CYP1A2 protein more ... CTD PMID:18486174 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of CYP1A2 mRNA and Hexachlorocyclohexane results in increased expression of CYP1A2 protein CTD PMID:12842176 more ... gamma-valerolactone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 gamma-valerolactone results in decreased activity of CYP1A2 protein CTD PMID:15916432 gemfibrozil decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Gemfibrozil results in decreased activity of CYP1A2 protein CTD PMID:26599973 gemfibrozil multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Gemfibrozil results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 genistein increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Genistein CTD PMID:12814970 genistein decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Genistein results in decreased activity of CYP1A2 protein CTD PMID:20806393 more ... genistein decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Genistein results in decreased expression of CYP1A2 mRNA CTD PMID:24967385 genistein increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Genistein CTD PMID:12814970 genistein increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Genistein CTD PMID:15587933 genkwanin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of genkwanin CTD PMID:19666078 gentamycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 gestodene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine more ... CTD PMID:16198659 and PMID:9305587 Ginkgolide A increases activity EXP 6480464 ginkgolide A results in increased activity of CYP1A2 protein CTD PMID:18421621 Ginkgolide A increases expression EXP 6480464 ginkgolide A results in increased expression of CYP1A2 mRNA CTD PMID:18421621 ginkgolide B multiple interactions EXP 6480464 ginkgolide B results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 ginkgolide B increases expression EXP 6480464 ginkgolide B results in increased expression of CYP1A2 mRNA CTD PMID:18421621 Glu-P-1 affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-amino-6-methyldipyrido(1 more ... CTD PMID:2655891 Glu-P-1 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 2-amino-6-methyldipyrido(1 more ... CTD PMID:28160022 Glu-P-1 increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-6-methyldipyrido(1 more ... CTD PMID:14725854 Glu-P-2 affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Glu-P-2 CTD PMID:2655891 Glu-P-2 increases expression ISO CYP1A2 (Homo sapiens) 6480464 Glu-P-2 results in increased expression of CYP1A2 mRNA CTD PMID:27644595 Glu-P-2 multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Glu-P-2 CTD PMID:28160022 glucoerucin increases expression EXP 6480464 glucoerucin results in increased expression of CYP1A2 protein CTD PMID:20833222 glucoerucin(1-) increases expression EXP 6480464 glucoerucin results in increased expression of CYP1A2 protein CTD PMID:20833222 glucoraphanin increases expression EXP 6480464 glucoraphanin results in increased expression of CYP1A2 protein CTD PMID:20833222 glucose multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 glutathione multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac more ... CTD PMID:20825217 more ... glycochenodeoxycholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA more ... CTD PMID:33819548 glycyrrhetinate multiple interactions EXP 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 glycyrrhetinic acid multiple interactions EXP 6480464 [brucine co-treated with Glycyrrhetinic Acid] results in decreased activity of CYP1A2 protein CTD PMID:21800547 griseofulvin affects expression ISO Cyp1a2 (Mus musculus) 6480464 Griseofulvin affects the expression of CYP1A2 mRNA CTD PMID:12735108 griseofulvin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Griseofulvin promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] CTD PMID:9029748 guanethidine multiple interactions EXP 6480464 Guanethidine inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] CTD PMID:16510159 GW 3965 increases expression ISO CYP1A2 (Homo sapiens) 6480464 GW 3965 results in increased expression of CYP1A2 mRNA CTD PMID:23041609 halocarban increases expression ISO CYP1A2 (Homo sapiens) 6480464 cloflucarban results in increased expression of CYP1A2 mRNA and cloflucarban results in increased expression of CYP1A2 protein CTD PMID:21784029 hemin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein more ... CTD PMID:22159698 and PMID:26747958 heroin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Heroin results in decreased activity of CYP1A2 protein CTD PMID:35914676 hesperetin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 hesperetin results in decreased activity of CYP1A2 protein CTD PMID:29753067 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CYP1A2 mRNA and Hexachlorobenzene results in increased expression of CYP1A2 protein CTD PMID:10696772 more ... hexane increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of n-hexane CTD PMID:16484137 hexane multiple interactions EXP 6480464 diallyl trisulfide inhibits the reaction [n-hexane results in increased expression of CYP1A2 protein] and n-hexane results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:28115069 huperzine A increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of huperzine A CTD PMID:12586202 hydralazine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 hydralazine multiple interactions EXP 6480464 Hydralazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 hydrocortisone succinate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [hydrocortisone hemisuccinate co-treated with Dimethyl Sulfoxide] results in increased expression of CYP1A2 CTD PMID:18347083 hydrogen peroxide increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of Hydrogen Peroxide CTD PMID:25061110 hydrogen peroxide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of CYP1A2 mRNA and Hydrogen Peroxide results in increased expression of CYP1A2 protein CTD PMID:36368423 hydrogen peroxide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Hydrogen Peroxide results in increased expression of CYP1A2 mRNA] CTD PMID:36368423 Hypaconitine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of hypaconitine CTD PMID:21550385 iberin multiple interactions EXP 6480464 iberin results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] CTD PMID:22664424 ibuprofen decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Ibuprofen results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 Icaritin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 icaritin results in decreased activity of CYP1A2 protein CTD PMID:29753067 ifosfamide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Ifosfamide results in increased expression of CYP1A2 mRNA CTD PMID:25596134 imipramine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Imipramine CTD PMID:15286053 imipramine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Imipramine CTD PMID:11714871 imipramine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine more ... CTD PMID:11714871 and PMID:15922009 imipramine oxide increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of imipramine N-oxide CTD PMID:27320963 imiprothrin increases expression EXP 6480464 imiprothrin results in increased expression of CYP1A2 mRNA CTD PMID:33638779 imiquimod multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the reaction [beta-Naphthoflavone results in increased metabolism of Imiquimod] CTD PMID:31111189 imiquimod affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Imiquimod CTD PMID:31111189 imiquimod increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Imiquimod metabolite CTD PMID:31111189 imiquimod increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Imiquimod CTD PMID:31111189 imiquimod multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Imiquimod] which results in increased chemical synthesis of Imiquimod metabolite CTD PMID:31111189 imperatorin increases expression ISO Cyp1a2 (Mus musculus) 6480464 imperatorin results in increased expression of CYP1A2 protein CTD PMID:18692084 indane decreases activity ISO CYP1A2 (Homo sapiens) 6480464 indan results in decreased activity of CYP1A2 protein CTD PMID:15916432 Indeno[1,2,3-cd]pyrene increases expression ISO CYP1A2 (Homo sapiens) 6480464 indeno(1 more ... CTD PMID:17253728 indirubin increases expression ISO CYP1A2 (Homo sapiens) 6480464 indirubin results in increased expression of CYP1A2 mRNA CTD PMID:15056799 indole-3-methanol increases expression ISO CYP1A2 (Homo sapiens) 6480464 indole-3-carbinol results in increased expression of CYP1A2 mRNA CTD PMID:28357125 indole-3-methanol increases expression EXP 6480464 indole-3-carbinol results in increased expression of CYP1A2 and indole-3-carbinol results in increased expression of CYP1A2 protein CTD PMID:22328411 more ... indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA and Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] CTD PMID:22129741 indole-3-methanol increases expression ISO Cyp1a2 (Mus musculus) 6480464 indole-3-carbinol results in increased expression of CYP1A2 CTD PMID:22328411 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of CYP1A2 mRNA CTD PMID:21396975 indole-3-methanol increases activity EXP 6480464 indole-3-carbinol results in increased activity of CYP1A2 and indole-3-carbinol results in increased activity of CYP1A2 protein CTD PMID:12147290 indolin-2-one increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-oxindole results in increased expression of CYP1A2 protein CTD PMID:36368423 indolin-2-one multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein] and IFNG protein inhibits the reaction [2-oxindole results in increased expression of CYP1A2 protein] CTD PMID:36368423 indometacin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 TLR4 protein affects the reaction [Indomethacin results in decreased activity of CYP1A2 protein] CTD PMID:12927920 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of CYP1A2 mRNA CTD PMID:16771604 indoxyl sulfate increases expression ISO CYP1A2 (Homo sapiens) 6480464 Indican results in increased expression of CYP1A2 mRNA CTD PMID:20000589 inulin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP1A2 mRNA CTD PMID:36331819 irilone decreases activity ISO CYP1A2 (Homo sapiens) 6480464 irilone results in decreased activity of CYP1A2 protein CTD PMID:29753067 iron dextran decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Iron-Dextran Complex results in decreased activity of CYP1A2 protein CTD PMID:9443932 iron dextran multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Iron-Dextran Complex inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:9443932 isocarbophos multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in decreased sulfation of and affects the activity of isocarbophos CTD PMID:24752505 isoimperatorin increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of isoimperatorin CTD PMID:25500267 isoliquiritigenin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 isoliquiritigenin inhibits the reaction [9 more ... CTD PMID:25110319 isoliquiritigenin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 isoliquiritigenin results in decreased activity of CYP1A2 protein CTD PMID:29753067 isopimpinellin increases expression ISO Cyp1a2 (Mus musculus) 6480464 isopimpinellin results in increased expression of CYP1A2 protein CTD PMID:18692084 isoprenaline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Isoproterenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 isoprenaline multiple interactions EXP 6480464 Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] and Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] CTD PMID:15710352 isoproturon increases activity ISO CYP1A2 (Homo sapiens) 6480464 isoproturon results in increased activity of CYP1A2 protein CTD PMID:22310298 isoproturon decreases activity ISO Cyp1a2 (Mus musculus) 6480464 isoproturon results in decreased activity of CYP1A2 protein CTD PMID:18420780 isoproturon increases expression ISO CYP1A2 (Homo sapiens) 6480464 isoproturon results in increased expression of CYP1A2 mRNA CTD PMID:22310298 Isosafrole multiple interactions EXP 6480464 isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] CTD PMID:12062927 Isosafrole decreases activity EXP 6480464 isosafrole results in decreased activity of CYP1A2 protein CTD PMID:12062927 Isosafrole increases expression EXP 6480464 isosafrole results in increased expression of CYP1A2 mRNA CTD PMID:11285323 Isosafrole increases expression ISO Cyp1a2 (Mus musculus) 6480464 isosafrole results in increased expression of CYP1A2 mRNA CTD PMID:8722114 Isoxanthohumol increases expression ISO CYP1A2 (Homo sapiens) 6480464 isoxanthohumol results in increased expression of CYP1A2 mRNA CTD PMID:15672752 Isradipine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Isradipine results in increased expression of CYP1A2 mRNA CTD PMID:27732883 ivermectin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Ivermectin results in increased expression of CYP1A2 mRNA CTD PMID:24998875 kaempferol increases expression ISO CYP1A2 (Homo sapiens) 6480464 kaempferol results in increased expression of CYP1A2 mRNA CTD PMID:19034627 kaempferol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 kaempferol results in decreased activity of CYP1A2 protein CTD PMID:20806393 more ... kaempferol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 kaempferol inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:21256954 kaempferol increases expression EXP 6480464 kaempferol results in increased expression of CYP1A2 mRNA CTD PMID:18421621 kaempferol multiple interactions EXP 6480464 kaempferol results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:18421621 ketoconazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] and Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] CTD PMID:24120545 and PMID:9305587 ketoconazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 ketoconazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Ketoconazole results in increased expression of CYP1A2 mRNA and Ketoconazole results in increased expression of CYP1A2 protein CTD PMID:25000292 ketoconazole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:15618748 and PMID:15916432 ketoconazole decreases activity EXP 6480464 Ketoconazole results in decreased activity of CYP1A2 protein CTD PMID:12814958 and PMID:15879494 ketoconazole multiple interactions EXP 6480464 Ketoconazole inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 ketoconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Ketoconazole inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] CTD PMID:1567206 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid deficiency results in increased expression of CYP1A2 mRNA and Ascorbic Acid deficiency results in increased expression of CYP1A2 protein CTD PMID:8269614 L-methionine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [3 more ... CTD PMID:27712037 more ... lansoprazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Lansoprazole results in increased expression of CYP1A2 mRNA and Lansoprazole results in increased expression of CYP1A2 protein CTD PMID:12623754 more ... lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP1A2 mRNA and Lansoprazole results in increased expression of CYP1A2 protein CTD PMID:14550749 more ... laquinimod increases expression EXP 6480464 laquinimod analog results in increased expression of CYP1A2 mRNA CTD PMID:28433708 lead nitrate decreases activity ISO CYP1A2 (Homo sapiens) 6480464 lead nitrate results in decreased activity of CYP1A2 protein CTD PMID:11162773 lead nitrate multiple interactions EXP 6480464 lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:8902619 lead(0) affects expression EXP 6480464 Lead affects the expression of CYP1A2 mRNA CTD PMID:23631153 lefetamine decreases alkylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased alkylation of lephetamine CTD PMID:26276083 leflunomide increases expression ISO CYP1A2 (Homo sapiens) 6480464 leflunomide results in increased expression of CYP1A2 mRNA CTD PMID:28988120 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP1A2 mRNA CTD PMID:24136188 lentinan decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Lentinan results in decreased expression of CYP1A2 CTD PMID:15630237 Licochalcone A decreases activity ISO CYP1A2 (Homo sapiens) 6480464 licochalcone A results in decreased activity of CYP1A2 protein CTD PMID:26100226 lidocaine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Lidocaine CTD PMID:15447735 linoleic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Linoleic Acid results in decreased activity of CYP1A2 protein CTD PMID:16978661 linuron decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased susceptibility to Linuron CTD PMID:29573710 lipoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A1 protein co-treated with CYP1A2 protein] affects the reaction [[Thioctic Acid results in decreased activity of POR protein] inhibits the reaction [aristolochic acid I results in increased abundance of [7-(deoxyadenosin-N(6)-yl)aristolactam I co-treated with 7-(deoxyguanosin-N(2)-yl)aristolactam I co-treated with 7-(deoxyadenosin-N(6)--yl)aristolactam II]]] CTD PMID:21932800 lipoic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 lipopolysaccharide multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Lipopolysaccharides inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:22466549 lipopolysaccharide decreases activity EXP 6480464 Lipopolysaccharides results in decreased activity of CYP1A2 protein CTD PMID:15542068 and PMID:15710352 lipopolysaccharide multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] more ... CTD PMID:15542068 and PMID:15710352 lithocholic acid decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Lithocholic Acid results in decreased activity of CYP1A2 protein CTD PMID:18420780 lithocholic acid increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Lithocholic Acid CTD PMID:18039809 lithocholic acid multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Lithocholic Acid] which results in increased chemical synthesis of Lithocholic Acid analog CTD PMID:18039809 loxapine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased metabolism of Loxapine CTD PMID:21826677 luteolin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Luteolin results in decreased activity of CYP1A2 protein CTD PMID:29753067 luteolin decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Luteolin results in decreased expression of CYP1A2 protein CTD PMID:33727136 luteolin increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to Luteolin CTD PMID:33727136 luteolin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased susceptibility to Luteolin] which results in decreased abundance of diosmetin more ... CTD PMID:33727136 Luteolin 7-methyl ether decreases activity ISO CYP1A2 (Homo sapiens) 6480464 hydroxygenkwanin results in decreased activity of CYP1A2 protein CTD PMID:34843882 Luteolin 7-methyl ether decreases activity EXP 6480464 hydroxygenkwanin results in decreased activity of CYP1A2 protein CTD PMID:34843882 lycopene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Lycopene co-treated with Atrazine] results in increased expression of CYP1A2 mRNA and Lycopene inhibits the reaction [Atrazine results in increased expression of CYP1A2 mRNA] CTD PMID:26775023 and PMID:36216167 lycopene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Lycopene results in increased expression of CYP1A2 mRNA CTD PMID:36216167 m-xylene decreases activity EXP 6480464 3-xylene results in decreased activity of CYP1A2 protein CTD PMID:8598570 m-xylene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-xylene] CTD PMID:8558417 m-xylene increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 3-xylene CTD PMID:8558417 Magnolol decreases activity ISO Cyp1a2 (Mus musculus) 6480464 magnolol results in decreased activity of CYP1A2 protein CTD PMID:19140158 malathion affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Malathion CTD PMID:15557345 malathion increases expression ISO CYP1A2 (Homo sapiens) 6480464 Malathion results in increased expression of CYP1A2 mRNA CTD PMID:22310298 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein more ... CTD PMID:23159886 mangiferin decreases activity EXP 6480464 mangiferin results in decreased activity of CYP1A2 protein CTD PMID:18053976 mangiferin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 mangiferin results in decreased activity of CYP1A2 protein CTD PMID:22815239 mangiferin increases expression ISO CYP1A2 (Homo sapiens) 6480464 mangiferin results in increased expression of CYP1A2 mRNA CTD PMID:22815239 mebendazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Mebendazole results in increased expression of CYP1A2 protein CTD PMID:12841937 mebendazole increases expression EXP 6480464 Mebendazole results in increased expression of CYP1A2 protein CTD PMID:12841937 Meclizine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] CTD PMID:15272053 Meclizine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Meclizine binds to and results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA CTD PMID:15272053 mefenamic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Mefenamic Acid results in decreased activity of CYP1A2 protein CTD PMID:18816299 mefenamic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 SOD1 protein inhibits the reaction [CYP1A2 protein results in increased oxidation of Mefenamic Acid] CTD PMID:33259822 mefenamic acid increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of Mefenamic Acid CTD PMID:33259822 mefenamic acid increases glutathionylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased glutathionylation of Mefenamic Acid analog CTD PMID:25372302 mefenamic acid increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Mefenamic Acid CTD PMID:25372302 MeIQ increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein mutant form results in increased metabolism of 2-amino-3 more ... CTD PMID:14744142 MeIQ multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] which results in increased activity of 2-amino-3 more ... CTD PMID:11585058 MeIQ multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2-amino-3 more ... CTD PMID:1567206 MeIQ decreases activity EXP 6480464 2-amino-3 more ... CTD PMID:1617633 MeIQ affects expression EXP 6480464 2-amino-3 more ... CTD PMID:1617633 MeIQ increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-3 more ... CTD PMID:14725854 MeIQ increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased activity of 2-amino-3 more ... CTD PMID:10775323 more ... MeIQ affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-amino-3 more ... CTD PMID:2655891 MeIQ multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with POR protein co-treated with OAT protein] results in increased susceptibility to 2-amino-3 more ... CTD PMID:10503888 more ... MeIQ increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of 2-amino-3 more ... CTD PMID:1617633 MeIQ affects binding ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein binds to 2-amino-3 more ... CTD PMID:9334905 MeIQx increases expression ISO Cyp1a2 (Mus musculus) 6480464 2-amino-3 more ... CTD PMID:23681119 MeIQx increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20307560 more ... MeIQx increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 2-amino-3 more ... CTD PMID:10503887 more ... MeIQx multiple interactions EXP 6480464 2-amino-3 more ... CTD PMID:12079509 more ... MeIQx affects oxidation EXP 6480464 CYP1A2 affects the oxidation of 2-amino-3 more ... CTD PMID:10503887 MeIQx increases activity ISO CYP1A2 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20307560 and PMID:2334931 MeIQx affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of 2-amino-3 more ... CTD PMID:2655891 MeIQx decreases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased activity of 2-amino-3 more ... CTD PMID:20192249 MeIQx increases expression EXP 6480464 2-amino-3 more ... CTD PMID:12079509 more ... MeIQx multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:10503888 more ... MeIQx multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 melatonin decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of Melatonin CTD PMID:15616152 melatonin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [ABCB6 gene mutant form results in decreased expression of CYP1A2 mRNA] inhibits the reaction [CYP1A2 protein results in increased metabolism of Melatonin] and [ABCB6 gene mutant form results in decreased expression of CYP1A2 protein] inhibits the reaction [CYP1A2 protein results in increased metabolism of Melatonin] CTD PMID:25623066 melatonin increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Melatonin CTD PMID:25623066 melatonin increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Melatonin CTD PMID:15616152 and PMID:22634058 melatonin affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Melatonin CTD PMID:15626586 and PMID:15824912 melatonin multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 melatonin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Melatonin results in decreased activity of CYP1A2 protein CTD PMID:19919601 melatonin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Melatonin CTD PMID:17565714 melatonin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Melatonin inhibits the reaction [CYP1A2 protein results in increased hydrolysis of Benzo(a)pyrene] CTD PMID:19919601 meloxicam multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which results in increased chemical synthesis of Pyruvaldehyde and CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam CTD PMID:33253783 melphalan multiple interactions EXP 6480464 Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 melphalan multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Melphalan inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 menadione multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of CYP1A2 mRNA CTD PMID:15603920 menadione increases activity EXP 6480464 Vitamin K 3 results in increased activity of CYP1A2 protein CTD PMID:15603920 menadione multiple interactions EXP 6480464 Vitamin K 3 inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 mercury atom multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] more ... CTD PMID:22579925 more ... mercury atom increases activity ISO Cyp1a2 (Mus musculus) 6480464 Mercury results in increased activity of CYP1A2 protein CTD PMID:22579925 mercury dichloride decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Mercuric Chloride results in decreased activity of CYP1A2 protein CTD PMID:11162773 mercury dichloride decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of CYP1A2 protein CTD PMID:37172713 mercury dichloride decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Mercuric Chloride results in decreased expression of CYP1A2 protein CTD PMID:37172713 mercury(0) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] more ... CTD PMID:22579925 more ... mercury(0) increases activity ISO Cyp1a2 (Mus musculus) 6480464 Mercury results in increased activity of CYP1A2 protein CTD PMID:22579925 metformin increases expression ISO CYP1A2 (Homo sapiens) 6480464 Metformin results in increased expression of CYP1A2 mRNA CTD PMID:19022234 metformin decreases expression EXP 6480464 Metformin results in decreased expression of CYP1A2 mRNA CTD PMID:25596134 methamphetamine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Methamphetamine metabolite CTD PMID:16038959 methidathion increases expression ISO Cyp1a2 (Mus musculus) 6480464 methidathion results in increased expression of CYP1A2 mRNA CTD PMID:34813904 methotrexate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Methotrexate inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP1A2 mRNA CTD PMID:15120968 methoxsalen decreases activity EXP 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:12814958 and PMID:15879494 methoxsalen decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:18420780 methoxsalen decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Methoxsalen results in decreased activity of CYP1A2 protein CTD PMID:8819299 methoxychlor multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Methoxychlor results in increased expression of CYP1A2 mRNA] CTD PMID:21252393 methoxychlor increases expression ISO CYP1A2 (Homo sapiens) 6480464 Methoxychlor results in increased expression of CYP1A2 mRNA CTD PMID:21924250 methoxychlor decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 more ... methoxychlor multiple interactions EXP 6480464 Methoxychlor results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:12919727 methoxychlor increases expression ISO Cyp1a2 (Mus musculus) 6480464 Methoxychlor results in increased expression of CYP1A2 mRNA CTD PMID:21252393 methoxychlor increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Methoxychlor CTD PMID:9047321 methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nisoldipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 methylarsonic acid increases expression EXP 6480464 monomethylarsonic acid results in increased expression of CYP1A2 mRNA CTD PMID:17481689 methylglyoxal multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Meloxicam] which results in increased chemical synthesis of Pyruvaldehyde CTD PMID:33253783 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of CYP1A2 mRNA CTD PMID:30744511 methylmercury chloride multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Mercury co-treated with methylmercuric chloride] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] more ... CTD PMID:36245390 metolachlor increases activity ISO CYP1A2 (Homo sapiens) 6480464 metolachlor results in increased activity of CYP1A2 protein CTD PMID:10813365 metronidazole multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 miconazole increases expression EXP 6480464 Miconazole results in increased expression of CYP1A2 mRNA CTD PMID:22262564 microcystin-LR increases expression ISO Cyp1a2 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of CYP1A2 mRNA CTD PMID:17383702 mifepristone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Dexamethasone co-treated with Mifepristone] promotes the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] more ... CTD PMID:19022236 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]] CTD PMID:17690134 mitomycin C decreases activity EXP 6480464 Mitomycin results in decreased activity of CYP1A2 protein CTD PMID:15696929 Mitragynine increases activity ISO CYP1A2 (Homo sapiens) 6480464 mitragynine results in increased activity of CYP1A2 protein CTD PMID:23274770 Mitragynine increases expression ISO CYP1A2 (Homo sapiens) 6480464 mitragynine results in increased expression of CYP1A2 mRNA and mitragynine results in increased expression of CYP1A2 protein CTD PMID:23274770 Monobutylphthalate decreases activity EXP 6480464 monobutyl phthalate results in decreased activity of CYP1A2 protein CTD PMID:27432241 monocrotophos increases expression EXP 6480464 Monocrotophos results in increased expression of CYP1A2 protein CTD PMID:21445290 monosodium L-glutamate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Sodium Glutamate co-treated with gallocatechol co-treated with Catechin co-treated with epigallocatechin gallate co-treated with epicatechin gallate co-treated with gallocatechol co-treated with gallocatechin gallate] affects the expression of CYP1A2 mRNA and [Sodium Glutamate co-treated with Tea] affects the expression of CYP1A2 mRNA CTD PMID:25663641 morphine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Morphine results in decreased activity of CYP1A2 protein CTD PMID:35914676 musk xylene increases expression EXP 6480464 musk xylene results in increased expression of CYP1A2 protein CTD PMID:10630706 musk xylene increases activity EXP 6480464 musk xylene results in increased activity of CYP1A2 protein CTD PMID:10630706 musk xylene increases expression ISO Cyp1a2 (Mus musculus) 6480464 musk xylene metabolite results in increased expression of CYP1A2 mRNA and musk xylene results in increased expression of CYP1A2 mRNA CTD PMID:9397191 mycophenolic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Mycophenolic Acid promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:25929522 myricetin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 myricetin results in decreased activity of CYP1A2 protein CTD PMID:29753067 myristicin affects oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the oxidation of myristicin CTD PMID:12523956 myristicin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 myristicin results in decreased activity of CYP1A2 protein CTD PMID:26091900 myristicin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Glutathione inhibits the reaction [myristicin results in decreased activity of CYP1A2 protein] CTD PMID:26091900 N'-(2,4-dimethylphenyl)-N-methylformamidine increases expression EXP 6480464 U 40481 results in increased expression of CYP1A2 protein CTD PMID:31029719 N,N-diethyl-m-toluamide increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of DEET CTD PMID:11854147 N,N-diethyl-m-toluamide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP1A2 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide increases expression ISO CYP1A2 (Homo sapiens) 6480464 DEET results in increased expression of CYP1A2 mRNA CTD PMID:19326769 and PMID:27091632 N,N-diisopropyltryptamine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [N and N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 N,N-diisopropyltryptamine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 N and N-diisopropyltryptamine analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 N,N-dimethyltryptamine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of N and N-Dimethyltryptamine CTD PMID:27320963 N-[3-(aminomethyl)benzyl]acetamidine multiple interactions EXP 6480464 N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein] CTD PMID:15542068 N-acetyl-1,4-benzoquinone imine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased chemical synthesis of and results in increased abundance of N-acetyl-4-benzoquinoneimine CTD PMID:19679878 N-acetyl-1,4-benzoquinone imine increases abundance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased abundance of N-acetyl-4-benzoquinoneimine CTD PMID:24661219 N-acetyl-L-cysteine multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] more ... CTD PMID:21424224 more ... N-acetyl-L-cysteine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Acetylcysteine] results in increased metabolism of Emodin metabolite CTD PMID:27989148 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression EXP 401794136 MG132 pretreatment increases expression of protein in liver of intestinal ischemia/reperfusion rats RGD N-desmethylclozapine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ciprofloxacin results in decreased activity of CYP1A2 protein] which results in increased abundance of norclozapine and Fluvoxamine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of norclozapine] CTD PMID:11151749 and PMID:18809730 N-desmethylclozapine increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 N-desmethylclozapine increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of norclozapine CTD PMID:12969762 N-Desmethyltamoxifen increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen CTD PMID:29285606 N-Desmethyltamoxifen multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of N-desmethyltamoxifen] which results in increased abundance of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 N-hydroxy-PhIP multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [[CYP1A2 protein co-treated with CYP1A1 protein] results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:16167840 more ... N-hydroxy-PhIP multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:1943715 N-nitrosodiethylamine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species and [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA CTD PMID:20118626 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CYP1A2 mRNA CTD PMID:19638242 more ... N-nitrosodiethylamine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of CYP1A2 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 mRNA more ... CTD PMID:18164116 more ... N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of CYP1A2 mRNA and Dimethylnitrosamine results in decreased expression of CYP1A2 protein CTD PMID:16997515 and PMID:17072980 NADP zwitterion multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1 more ... CTD PMID:11714871 more ... NADP(+) multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with NADP co-treated with Glutathione] results in increased glutathionylation of and results in increased activity of 7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1 more ... CTD PMID:11714871 more ... naphthalene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 naphthalene inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 2-hydroxyestradiol] and naphthalene inhibits the reaction [CYP1A2 protein results in increased metabolism of Estradiol] CTD PMID:16790556 naphthalene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 naphthalene analog results in decreased activity of CYP1A2 protein and naphthalene results in decreased activity of CYP1A2 protein CTD PMID:15916432 and PMID:16790556 naringin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 naringin results in decreased activity of CYP1A2 protein CTD PMID:21053930 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CYP1A2 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of CYP1A2 mRNA CTD PMID:33819548 neomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 nicardipine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Methylcholanthrene promotes the reaction [Nicardipine results in increased expression of CYP1A2 mRNA] and Nicardipine promotes the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] CTD PMID:20067464 nicardipine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Nicardipine results in increased expression of CYP1A2 mRNA CTD PMID:20067464 nicardipine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nicardipine results in decreased activity of CYP1A2 protein CTD PMID:15863898 nickel atom decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Nickel results in decreased expression of CYP1A2 mRNA CTD PMID:24768652 nickel dichloride decreases expression ISO CYP1A2 (Homo sapiens) 6480464 nickel chloride results in decreased expression of CYP1A2 protein CTD PMID:21784029 niclosamide decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Niclosamide results in decreased activity of CYP1A2 protein CTD PMID:11124226 niclosamide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Niclosamide results in increased expression of CYP1A2 mRNA CTD PMID:28284560 nicotine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nicotine results in decreased activity of CYP1A2 protein CTD PMID:15916432 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of CYP1A2 mRNA CTD PMID:26463278 nicotine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Nicotine results in increased expression of CYP1A2 protein CTD PMID:11849738 nifedipine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nifedipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 nifedipine decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Nifedipine results in decreased activity of CYP1A2 protein CTD PMID:18420780 nifedipine multiple interactions EXP 6480464 Nifedipine inhibits the reaction [CYP1A2 protein results in increased metabolism of 3-cyano-7-ethoxycoumarin] CTD PMID:19858067 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 nimesulide increases glutathionylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased glutathionylation of nimesulide CTD PMID:26524229 nisoldipine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Nisoldipine results in decreased activity of CYP1A2 protein CTD PMID:10805063 nitroaniline increases expression EXP 6480464 nitroaniline analog results in increased expression of CYP1A2 mRNA and nitroaniline analog results in increased expression of CYP1A2 protein CTD PMID:9545601 nitroaniline increases activity EXP 6480464 nitroaniline analog results in increased activity of CYP1A2 protein CTD PMID:9545601 nitrofurantoin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Nitrofurantoin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 nitroglycerin affects expression EXP 401900296 Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart] RGD nitroglycerin decreases expression EXP 401900656 nitroglycerin decreased expression of Cyp1a2 protein in thoracic aorta of rats RGD nobiletin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of nobiletin CTD PMID:22743247 Nonylphenol increases expression ISO CYP1A2 (Homo sapiens) 6480464 nonylphenol results in increased expression of CYP1A2 mRNA and nonylphenol results in increased expression of CYP1A2 protein CTD PMID:34974051 norfloxacin affects binding EXP 6480464 Norfloxacin binds to CYP1A2 protein CTD PMID:8905919 norfloxacin multiple interactions EXP 6480464 Norfloxacin inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:8905919 norgestimate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with norgestimate] results in decreased activity of CYP1A2 protein CTD PMID:16291717 nortriptyline increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 Nortriptyline results in increased metabolism of CYP1A2 protein CTD PMID:18359012 notoginsenoside R1 decreases activity EXP 6480464 notoginsenoside R1 results in decreased activity of CYP1A2 protein CTD PMID:25834921 Notopterol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of notopterol CTD PMID:32198085 Notopterol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of notopterol] promotes the reaction [Glutathione binds to notopterol] CTD PMID:32198085 o-anisidine increases expression EXP 6480464 2-anisidine results in increased expression of CYP1A2 CTD PMID:11409192 o-anisidine increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 2-anisidine CTD PMID:15828049 O-methyleugenol increases expression ISO CYP1A2 (Homo sapiens) 6480464 methyleugenol results in increased expression of CYP1A2 mRNA CTD PMID:32234424 obeticholic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 obeticholic acid inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of Acetaminophen] and obeticholic acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:27939613 obeticholic acid decreases expression EXP 6480464 obeticholic acid results in decreased expression of CYP1A2 mRNA CTD PMID:35267068 obeticholic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 mRNA and [Dietary Fats co-treated with obeticholic acid] results in decreased expression of CYP1A2 protein CTD PMID:35267068 obeticholic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 obeticholic acid results in decreased activity of CYP1A2 protein CTD PMID:27939613 obeticholic acid decreases expression ISO CYP1A2 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP1A2 mRNA CTD PMID:27939613 ochratoxin A increases expression ISO CYP1A2 (Homo sapiens) 6480464 ochratoxin A results in increased expression of CYP1A2 mRNA and ochratoxin A results in increased expression of CYP1A2 protein CTD PMID:21834667 and PMID:30291945 ochratoxin A increases expression ISO Cyp1a2 (Mus musculus) 6480464 ochratoxin A results in increased expression of CYP1A2 mRNA and ochratoxin A results in increased expression of CYP1A2 protein CTD PMID:30291945 ochratoxin A increases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased susceptibility to ochratoxin A CTD PMID:11189750 more ... Octachlorostyrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 octachlorostyrene results in increased activity of CYP1A2 protein CTD PMID:19525444 Octachlorostyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 octachlorostyrene results in increased expression of CYP1A2 mRNA CTD PMID:19525444 octamethylcyclotetrasiloxane multiple interactions EXP 6480464 octamethylcyclotetrasiloxane results in decreased expression of and results in increased activity of CYP1A2 protein CTD PMID:36100151 ofloxacin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Ofloxacin co-treated with Clarithromycin] inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:11408986 okadaic acid multiple interactions EXP 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid CTD PMID:26374342 okadaic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of and results in increased susceptibility to Okadaic Acid CTD PMID:26374342 okanin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 okanin results in decreased activity of CYP1A2 protein CTD PMID:29753067 olanzapine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of olanzapine CTD PMID:15545309 and PMID:15883149 olanzapine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Fluvoxamine inhibits the reaction [CYP1A2 protein affects the metabolism of olanzapine] CTD PMID:15545309 oleanolic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Oleanolic Acid inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:15043991 oleanolic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Oleanolic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:23948738 oleanolic acid decreases expression EXP 6480464 Oleanolic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:18706400 oleanolic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Oleanolic Acid results in decreased activity of CYP1A2 protein CTD PMID:15043991 oleic acid decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Oleic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:30611723 oleic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Farnesol analog inhibits the reaction [Oleic Acid results in decreased expression of CYP1A2 mRNA] CTD PMID:30611723 Olivacine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 olivacine analog results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:14709624 Olivacine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of olivacine analog CTD PMID:14709624 oltipraz increases expression EXP 6480464 oltipraz results in increased expression of CYP1A2 mRNA CTD PMID:8625305 oltipraz increases expression ISO Cyp1a2 (Mus musculus) 6480464 oltipraz results in increased expression of CYP1A2 mRNA CTD PMID:22496397 oltipraz multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NFE2L2 protein affects the reaction [oltipraz results in increased expression of CYP1A2 mRNA] CTD PMID:22496397 oltipraz increases activity EXP 6480464 oltipraz results in increased activity of CYP1A2 protein CTD PMID:8625305 oltipraz affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of oltipraz CTD PMID:15831204 and PMID:15920769 oltipraz decreases activity ISO CYP1A2 (Homo sapiens) 6480464 oltipraz metabolite results in decreased activity of CYP1A2 protein and oltipraz results in decreased activity of CYP1A2 protein CTD PMID:10775323 oltipraz multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 oltipraz inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3 more ... CTD PMID:10775323 omeprazole increases activity ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in increased activity of CYP1A2 promoter and Omeprazole results in increased activity of CYP1A2 protein CTD PMID:18502397 more ... omeprazole decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:18420780 omeprazole multiple interactions EXP 6480464 [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA CTD PMID:22687989 omeprazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in increased expression of CYP1A2 mRNA and Omeprazole results in increased expression of CYP1A2 protein CTD PMID:12040753 more ... omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of CYP1A2 mRNA and Omeprazole results in increased expression of CYP1A2 protein CTD PMID:19118567 more ... omeprazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Omeprazole results in increased expression of CYP1A2 protein] which results in decreased alkylation of Phenacetin more ... CTD PMID:15802389 more ... omeprazole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Omeprazole results in decreased activity of CYP1A2 protein CTD PMID:16035375 Ondansetron affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Ondansetron CTD PMID:15286053 organophosphorus compound multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine] CTD PMID:15922009 organoselenium compound multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Organoselenium Compounds binds to and results in decreased activity of CYP1A2 protein CTD PMID:21732699 orphenadrine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Orphenadrine inhibits the reaction [CYP1A2 protein results in decreased ethylation of 7-ethoxy-4-trifluoromethylcoumarin] and Orphenadrine inhibits the reaction [CYP1A2 protein results in increased chemical synthesis of 7-hydroxy-4-trifluoromethylcoumarin] CTD PMID:9241656 orphenadrine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Orphenadrine results in decreased activity of CYP1A2 protein CTD PMID:9241656 orphenadrine multiple interactions EXP 6480464 Orphenadrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 ortho-Aminoazotoluene increases activity ISO Cyp1a2 (Mus musculus) 6480464 o-Aminoazotoluene results in increased activity of CYP1A2 protein CTD PMID:15863256 ortho-Aminoazotoluene increases expression ISO Cyp1a2 (Mus musculus) 6480464 o-Aminoazotoluene results in increased expression of CYP1A2 mRNA CTD PMID:10887293 and PMID:14562683 Oxadiazon increases expression ISO Cyp1a2 (Mus musculus) 6480464 oxadiazon results in increased expression of CYP1A2 mRNA CTD PMID:26710982 oxfendazole multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA more ... CTD PMID:18754104 and PMID:20033131 oxolane increases expression ISO Cyp1a2 (Mus musculus) 6480464 tetrahydrofuran results in increased expression of CYP1A2 mRNA CTD PMID:28495613 oxolane multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I2 protein affects the reaction [tetrahydrofuran results in increased expression of CYP1A2 mRNA] and NR1I3 protein affects the reaction [tetrahydrofuran results in increased expression of CYP1A2 mRNA] CTD PMID:28495613 ozone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 mRNA] and AHR protein affects the reaction [Ozone results in increased expression of CYP1A2 protein] CTD PMID:19536146 ozone decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Ozone results in decreased expression of CYP1A2 mRNA CTD PMID:16183385 ozone increases expression ISO CYP1A2 (Homo sapiens) 6480464 Ozone results in increased expression of CYP1A2 mRNA and Ozone results in increased expression of CYP1A2 protein CTD PMID:19536146 p-cresol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 4-cresol CTD PMID:16174805 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of CYP1A2 mRNA CTD PMID:15585946 paclitaxel decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Paclitaxel results in decreased activity of CYP1A2 protein CTD PMID:19909766 pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of CYP1A2 mRNA and pantoprazole results in increased expression of CYP1A2 protein CTD PMID:25626140 and PMID:9152597 papaverine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Papaverine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 paracetamol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CYP1A2 mRNA more ... CTD PMID:11376689 more ... paracetamol increases expression ISO CYP1A2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CYP1A2 mRNA CTD PMID:33811995 paracetamol decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA CTD PMID:32112222 paracetamol increases chemical synthesis EXP 6480464 CYP1A2 protein results in increased chemical synthesis of Acetaminophen CTD PMID:28438436 paracetamol increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Acetaminophen CTD PMID:12401345 more ... paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA CTD PMID:12969438 and PMID:21807079 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP1A2 mRNA CTD PMID:11245408 and PMID:17366322 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP1A2 protein CTD PMID:18798224 paracetamol multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen more ... CTD PMID:12969438 more ... paracetamol increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Acetaminophen CTD PMID:10977129 and PMID:19002106 paracetamol increases abundance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased abundance of Acetaminophen CTD PMID:10445756 paracetamol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen results in increased expression of CYP1A2 mRNA and Acetaminophen results in increased expression of CYP1A2 protein CTD PMID:12958197 more ... paracetamol affects expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP1A2 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen more ... CTD PMID:19135037 more ... paracetamol increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of Acetaminophen CTD PMID:10811468 paracetamol increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased metabolism of Acetaminophen CTD PMID:20566340 paracetamol decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Acetaminophen results in decreased expression of CYP1A2 mRNA and Acetaminophen results in decreased expression of CYP1A2 protein CTD PMID:15576447 more ... paracetamol increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased susceptibility to Acetaminophen CTD PMID:16141365 more ... paraquat increases activity EXP 6480464 Paraquat results in increased activity of CYP1A2 protein CTD PMID:20888808 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CYP1A2 mRNA and Paraquat results in increased expression of CYP1A2 protein CTD PMID:20888808 and PMID:23159886 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of and results in increased activity of CYP1A2 protein more ... CTD PMID:23159886 parathion affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Parathion CTD PMID:12669189 more ... parathion increases expression ISO CYP1A2 (Homo sapiens) 6480464 Parathion results in increased expression of CYP1A2 mRNA CTD PMID:26196221 PCB138 decreases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 results in decreased susceptibility to 2 more ... CTD PMID:21571617 PCB138 multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 2 more ... CTD PMID:20961953 pedalitin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 pedalitin results in decreased activity of CYP1A2 protein CTD PMID:29753067 pelargonidin increases expression ISO CYP1A2 (Homo sapiens) 6480464 pelargonidin results in increased expression of CYP1A2 mRNA CTD PMID:23419638 pentachlorobenzene increases expression EXP 6480464 pentachlorobenzene results in increased expression of CYP1A2 protein CTD PMID:10696772 pentachlorophenol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CYP1A2 mRNA CTD PMID:23892564 pentobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pentobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 Pentoxifylline decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Pentoxifylline results in decreased activity of CYP1A2 protein CTD PMID:11465391 perampanel increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of perampanel CTD PMID:35200000 perfluorooctane-1-sulfonic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP1A2 protein results in increased oxidation of Oxazines] CTD PMID:21964418 perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP1A2 mRNA more ... CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased activity of CYP1A2 protein CTD PMID:31809754 perfluorooctane-1-sulfonic acid affects expression ISO CYP1A2 (Homo sapiens) 6480464 perfluorooctane sulfonic acid affects the expression of CYP1A2 mRNA CTD PMID:31809754 perfluorooctane-1-sulfonic acid increases expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP1A2 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of CYP1A2 mRNA CTD PMID:18281256 perfluorooctanoic acid affects expression ISO CYP1A2 (Homo sapiens) 6480464 perfluorooctanoic acid affects the expression of CYP1A2 mRNA CTD PMID:31809754 perfluorooctanoic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased activity of CYP1A2 protein CTD PMID:31809754 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA and perfluorooctanoic acid results in decreased expression of CYP1A2 protein CTD PMID:16221955 more ... perfluorooctanoic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of CYP1A2 mRNA] CTD PMID:20118188 perfluorooctanoic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of CYP1A2 mRNA CTD PMID:20118188 perhexiline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of [perhexiline maleate results in increased abundance of Perhexiline] more ... CTD PMID:18493746 and PMID:36083301 permethrin increases expression ISO CYP1A2 (Homo sapiens) 6480464 Permethrin results in increased expression of CYP1A2 mRNA and Permethrin results in increased expression of CYP1A2 protein CTD PMID:21784029 phenacetin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:11465391 more ... phenacetin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:12401345 more ... phenacetin affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:11751525 more ... phenacetin increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of Phenacetin and CYP1A2 protein results in increased oxidation of Phenacetin analog CTD PMID:10985777 more ... phenacetin decreases ethylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased ethylation of Phenacetin CTD PMID:11303964 more ... phenacetin affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15231049 more ... phenacetin increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:12222751 more ... phenacetin decreases ethylation EXP 6480464 CYP1A2 protein results in decreased ethylation of Phenacetin CTD PMID:11911841 and PMID:12064368 phenacetin multiple interactions EXP 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen more ... CTD PMID:28438436 and PMID:8905919 phenacetin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Phenacetin results in increased expression of CYP1A2 protein CTD PMID:15742976 phenacetin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein results in increased metabolism of Phenacetin] which results in increased chemical synthesis of Acetaminophen and Phenacetin inhibits the reaction [CYP1A2 protein results in increased oxidation of Uroporphyrinogens] CTD PMID:1567206 and PMID:30503582 phenacetin increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of Phenacetin CTD PMID:10445756 and PMID:30503582 phenacetin affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Phenacetin CTD PMID:15742976 phenacetin increases activity ISO CYP1A2 (Homo sapiens) 6480464 Phenacetin results in increased activity of CYP1A2 protein CTD PMID:15802386 phenanthrene increases activity ISO Cyp1a2 (Mus musculus) 6480464 phenanthrene results in increased activity of CYP1A2 protein CTD PMID:8001243 phenanthrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 phenanthrene results in increased expression of CYP1A2 mRNA and phenanthrene results in increased expression of CYP1A2 protein CTD PMID:31181217 phenanthrene increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of phenanthrene CTD PMID:27137136 phenanthrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA and CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene CTD PMID:19766613 and PMID:7750161 phenanthrene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased oxidation of phenanthrene] which results in increased abundance of 9-phenanthrol and CYP1A2 protein results in increased metabolism of and results in increased activity of phenanthrene CTD PMID:19766613 and PMID:27137136 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CYP1A2 mRNA CTD PMID:20360939 phenethyl caffeate decreases expression EXP 6480464 caffeic acid phenethyl ester results in decreased expression of CYP1A2 protein CTD PMID:22291063 phenethyl isothiocyanate decreases activity ISO CYP1A2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased activity of CYP1A2 mRNA CTD PMID:20442190 phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:22664424 phenethyl isothiocyanate multiple interactions EXP 6480464 phenethyl isothiocyanate results in increased activity of [CYP1A1 protein co-treated with CYP1A2 protein] CTD PMID:22664424 phenethyl isothiocyanate decreases expression ISO CYP1A2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:20025923 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of CYP1A2 protein CTD PMID:20025923 phenethyl isothiocyanate increases expression ISO CYP1A2 (Homo sapiens) 6480464 phenethyl isothiocyanate results in increased expression of CYP1A2 mRNA CTD PMID:15672752 and PMID:20442190 phenobarbital multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA and Meclizine inhibits the reaction [[Phenobarbital results in increased activity of NR1I3 protein] which results in increased expression of CYP1A2 mRNA] CTD PMID:15272053 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA CTD PMID:20226384 more ... phenobarbital increases expression ISO CYP1A2 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA and Phenobarbital results in increased expression of CYP1A2 protein CTD PMID:19118567 more ... phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP1A2 mRNA and Phenobarbital results in decreased expression of CYP1A2 protein CTD PMID:11328961 more ... phenobarbital affects expression ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital affects the expression of CYP1A2 mRNA CTD PMID:23091169 phenobarbital decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Phenobarbital results in decreased activity of CYP1A2 protein CTD PMID:19909766 phenobarbital increases activity ISO CYP1A2 (Homo sapiens) 6480464 Phenobarbital results in increased activity of CYP1A2 protein CTD PMID:19118567 phenobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP1A2 mRNA and Phenobarbital results in increased expression of CYP1A2 protein CTD PMID:10064569 more ... phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with beta-Naphthoflavone] results in increased expression of CYP1A2 protein more ... CTD PMID:18486174 more ... phenobarbital multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Phenobarbital co-treated with 2-amino-3 more ... CTD PMID:16109766 more ... phenobarbital increases activity ISO Cyp1a2 (Mus musculus) 6480464 Phenobarbital results in increased activity of CYP1A2 protein CTD PMID:10064569 phenol affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the susceptibility to Phenol CTD PMID:8242868 phenthoate increases expression ISO CYP1A2 (Homo sapiens) 6480464 phenthoate results in increased expression of CYP1A2 mRNA CTD PMID:22310298 phenylephrine multiple interactions EXP 6480464 Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] more ... CTD PMID:16510159 phenytoin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin CTD PMID:23397584 PhIP increases activity ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein polymorphism results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:12949046 more ... PhIP affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP affects the metabolism of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:22131055 PhIP increases expression ISO CYP1A2 (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of CYP1A2 mRNA CTD PMID:20307560 more ... PhIP increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:14725854 more ... PhIP increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:17279779 PhIP increases activity EXP 6480464 CYP1A2 protein results in increased activity of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:15598703 PhIP increases response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased susceptibility to 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:1943715 PhIP increases hydroxylation ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased hydroxylation of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:16167840 PhIP affects response to substance ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:2023932 PhIP increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 results in increased oxidation of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:10503887 PhIP multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:10503888 more ... PhIP multiple interactions EXP 6480464 [1-Naphthylisothiocyanate co-treated with 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:12706856 more ... PhIP affects oxidation EXP 6480464 CYP1A2 affects the oxidation of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:10503887 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:12706856 more ... PhIP increases metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine CTD PMID:17279779 PhIP multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [CYP1A2 protein co-treated with 2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:16167840 more ... phlorizin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Phlorhizin results in decreased expression of CYP1A2 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate promotes the reaction [FOS protein binds to CYP1A2 enhancer] more ... CTD PMID:10620351 phorbol 13-acetate 12-myristate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:1313028 phorone increases expression ISO Cyp1a2 (Mus musculus) 6480464 phorone results in increased expression of CYP1A2 mRNA CTD PMID:24494203 phosphatidylcholine affects activity ISO CYP1A2 (Homo sapiens) 6480464 Phosphatidylcholines affects the activity of CYP1A2 protein CTD PMID:15966743 phosphatidylethanolamine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 phosphatidylethanolamine results in increased stability of and results in increased activity of CYP1A2 protein CTD PMID:15966743 physcion decreases activity ISO CYP1A2 (Homo sapiens) 6480464 physcione results in decreased activity of CYP1A2 protein CTD PMID:27633141 and PMID:33438235 pimobendan decreases methylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased methylation of pimobendan CTD PMID:10611143 pinocembrin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 pinocembrin results in decreased activity of CYP1A2 protein CTD PMID:29753067 Pipermethystine increases expression EXP 6480464 pipermethystine results in increased expression of CYP1A2 protein CTD PMID:17329236 piperonyl butoxide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA and Piperonyl Butoxide results in increased expression of CYP1A2 protein CTD PMID:21784029 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA CTD PMID:18544911 and PMID:20735435 piperonyl butoxide increases expression ISO Cyp1a2 (Mus musculus) 6480464 Piperonyl Butoxide results in increased expression of CYP1A2 mRNA and Piperonyl Butoxide results in increased expression of CYP1A2 protein CTD PMID:30572783 more ... piperonyl butoxide multiple interactions EXP 6480464 Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of CYP1A2 mRNA] CTD PMID:18544911 pirinixic acid multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:17962186 more ... pirinixic acid decreases expression ISO Cyp1a2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CYP1A2 mRNA CTD PMID:17962186 more ... pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CYP1A2 mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP1A2 mRNA CTD PMID:19710929 poly(styrene) multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] CTD PMID:19909766 poly(styrene) affects activity ISO CYP1A2 (Homo sapiens) 6480464 styrofoam analog affects the activity of CYP1A2 protein CTD PMID:19909766 potassium dichromate increases expression ISO Cyp1a2 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of CYP1A2 mRNA CTD PMID:23608068 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP1A2 mRNA CTD PMID:27225895 pravastatin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Pravastatin results in decreased expression of CYP1A2 mRNA CTD PMID:27225895 prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] more ... CTD PMID:16510159 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA CTD PMID:15596064 more ... pregnenolone 16alpha-carbonitrile multiple interactions EXP 6480464 NR1I2 gene mutant form inhibits the reaction [Pregnenolone Carbonitrile results in decreased expression of CYP1A2 mRNA] CTD PMID:29548889 pregnenolone 16alpha-carbonitrile increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP1A2 mRNA CTD PMID:27413110 and PMID:31388680 pregnenolone 16alpha-carbonitrile multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] CTD PMID:28428138 primaquine increases activity ISO CYP1A2 (Homo sapiens) 6480464 Primaquine results in increased activity of CYP1A2 promoter CTD PMID:18502397 primaquine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Primaquine CTD PMID:19616568 primaquine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased expression of HBG2 protein] which affects the susceptibility to Primaquine CTD PMID:19616568 primaquine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Primaquine results in increased expression of CYP1A2 mRNA CTD PMID:12451431 more ... primaquine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Primaquine CTD PMID:12920490 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of CYP1A2 mRNA and prochloraz results in increased expression of CYP1A2 protein CTD PMID:25182419 and PMID:33150952 prochloraz increases expression ISO CYP1A2 (Homo sapiens) 6480464 prochloraz results in increased expression of CYP1A2 mRNA and prochloraz results in increased expression of CYP1A2 protein CTD PMID:21784029 and PMID:33150952 profenofos increases expression ISO CYP1A2 (Homo sapiens) 6480464 profenofos results in increased expression of CYP1A2 mRNA CTD PMID:22310298 profenofos decreases activity ISO CYP1A2 (Homo sapiens) 6480464 profenofos results in decreased activity of CYP1A2 protein CTD PMID:20183062 propachlor increases activity ISO CYP1A2 (Homo sapiens) 6480464 propachlor results in increased activity of CYP1A2 protein CTD PMID:10813365 propiconazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 propiconazole results in increased expression of CYP1A2 mRNA CTD PMID:19409404 more ... propiconazole increases activity ISO CYP1A2 (Homo sapiens) 6480464 propiconazole results in increased activity of CYP1A2 protein CTD PMID:30458266 propiconazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [propiconazole co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA more ... CTD PMID:30293151 more ... propiconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 propiconazole results in increased expression of CYP1A2 mRNA CTD PMID:16730040 more ... propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP1A2 mRNA and propiconazole results in increased expression of CYP1A2 protein CTD PMID:15603923 more ... propiconazole increases activity EXP 6480464 propiconazole results in increased activity of CYP1A2 protein CTD PMID:30293151 and PMID:3190755 propranolol affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Propranolol CTD PMID:15286053 propranolol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Propranolol results in increased expression of CYP1A2 protein CTD PMID:15618653 propranolol multiple interactions EXP 6480464 Propranolol inhibits the reaction [Clenbuterol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] and Propranolol inhibits the reaction [Isoproterenol inhibits the reaction [Lipopolysaccharides results in decreased activity of CYP1A2 protein]] CTD PMID:15710352 propylparaben decreases activity EXP 6480464 propylparaben results in decreased activity of CYP1A2 protein CTD PMID:27432241 protopine increases expression ISO CYP1A2 (Homo sapiens) 6480464 protopine results in increased expression of CYP1A2 mRNA CTD PMID:21419197 pterostilbene decreases activity ISO Cyp1a2 (Mus musculus) 6480464 pterostilbene results in decreased activity of CYP1A2 protein CTD PMID:16684708 pterostilbene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 pterostilbene results in decreased activity of CYP1A2 protein CTD PMID:30394306 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of CYP1A2 mRNA CTD PMID:22431067 pyrene increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of pyrene CTD PMID:15016593 pyrene increases expression EXP 6480464 pyrene results in increased expression of CYP1A2 mRNA CTD PMID:30240548 pyrene increases expression ISO Cyp1a2 (Mus musculus) 6480464 pyrene results in increased expression of CYP1A2 mRNA and pyrene results in increased expression of CYP1A2 protein CTD PMID:17618724 and PMID:26160115 pyrene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fluoranthene co-treated with pyrene co-treated with benz(a)anthracene co-treated with chrysene co-treated with benzo(b)fluoranthene co-treated with benzo(k)fluoranthene co-treated with Benzo(a)pyrene] results in increased expression of CYP1A2 mRNA and pyrene results in increased expression of and results in increased activity of CYP1A2 protein CTD PMID:17618724 and PMID:7750161 pyridine increases expression EXP 6480464 pyridine results in increased expression of CYP1A2 mRNA and pyridine results in increased expression of CYP1A2 protein CTD PMID:10413312 more ... pyridine increases activity EXP 6480464 pyridine results in increased activity of CYP1A2 protein CTD PMID:10413312 more ... pyrogallol increases expression ISO Cyp1a2 (Mus musculus) 6480464 Pyrogallol results in increased expression of CYP1A2 mRNA CTD PMID:18789925 pyrogallol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [Pyrogallol results in increased activity of CYP1A2 protein] and resveratrol inhibits the reaction [Pyrogallol results in increased expression of CYP1A2 mRNA] CTD PMID:18789925 pyrogallol increases activity ISO Cyp1a2 (Mus musculus) 6480464 Pyrogallol results in increased activity of CYP1A2 protein CTD PMID:18789925 pyrrolidines affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Pyrrolidines CTD PMID:21053377 quercetin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] more ... CTD PMID:10620351 more ... quercetin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Quercetin co-treated with Oxygen] results in increased expression of CYP1A2 mRNA CTD PMID:29432836 quercetin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Quercetin results in decreased activity of CYP1A2 protein CTD PMID:12949046 more ... quercetin decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Quercetin results in decreased activity of CYP1A2 protein CTD PMID:18420780 quercetin increases expression ISO CYP1A2 (Homo sapiens) 6480464 Quercetin results in increased expression of CYP1A2 mRNA CTD PMID:19034627 and PMID:21256954 quercetin affects activity ISO CYP1A2 (Homo sapiens) 6480464 Quercetin affects the activity of CYP1A2 protein CTD PMID:21053930 quercetin increases expression EXP 6480464 Quercetin results in increased expression of CYP1A2 mRNA CTD PMID:18421621 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [CYP1A2 results in increased activity of 2-amino-3-methylimidazo(4 more ... CTD PMID:11752233 and PMID:18421621 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of CYP1A2 mRNA CTD PMID:20033131 quinaldine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 2-methylquinoline results in decreased activity of CYP1A2 protein CTD PMID:15916432 quinidine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Quinidine affects the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] CTD PMID:19053182 quinidine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Quinidine results in decreased activity of CYP1A2 protein CTD PMID:15916432 quinine increases expression ISO CYP1A2 (Homo sapiens) 6480464 Quinine results in increased expression of CYP1A2 mRNA CTD PMID:12451431 quinizarin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 1 and 4-dihydroxyanthraquinone results in decreased activity of CYP1A2 protein CTD PMID:33438235 quinoline decreases activity ISO CYP1A2 (Homo sapiens) 6480464 quinoline analog results in decreased activity of CYP1A2 protein CTD PMID:15916432 rabeprazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Rabeprazole results in increased expression of CYP1A2 mRNA CTD PMID:12623754 rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of CYP1A2 mRNA CTD PMID:25626140 reactive oxygen species multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[dicyclanil co-treated with Diethylnitrosamine] results in increased expression of CYP1A2 mRNA] which results in increased abundance of Reactive Oxygen Species CTD PMID:20118626 reserpine multiple interactions EXP 6480464 [Reserpine results in decreased abundance of Catecholamines] promotes the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A2 protein] more ... CTD PMID:16510159 resveratrol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:10496959 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA] more ... CTD PMID:18789925 and PMID:26204831 resveratrol decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Resveratrol results in decreased activity of CYP1A2 protein CTD PMID:11714871 and PMID:30394306 resveratrol decreases activity ISO Cyp1a2 (Mus musculus) 6480464 resveratrol analog results in decreased activity of CYP1A2 protein and resveratrol results in decreased activity of CYP1A2 protein CTD PMID:16684708 more ... resveratrol affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of resveratrol CTD PMID:15276085 Retrorsine increases expression EXP 6480464 retrorsine results in increased expression of CYP1A2 CTD PMID:24799337 Rhein decreases activity ISO CYP1A2 (Homo sapiens) 6480464 rhein results in decreased activity of CYP1A2 protein CTD PMID:27633141 and PMID:33438235 rifampicin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Tetrachlorodibenzodioxin co-treated with Rifampin] results in increased expression of CYP1A2 mRNA and Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 and PMID:29162470 rifampicin increases expression ISO Cyp1a2 (Mus musculus) 6480464 Rifampin results in increased expression of CYP1A2 mRNA CTD PMID:30503582 rifampicin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [[NR1I3 protein co-treated with NR1I2 protein] results in increased susceptibility to Rifampin] which results in decreased expression of CYP1A2 protein CTD PMID:25835148 rifampicin multiple interactions EXP 6480464 Rifampin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 rifampicin increases expression ISO CYP1A2 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP1A2 mRNA and Rifampin results in increased expression of CYP1A2 protein CTD PMID:15977188 and PMID:17590308 ritonavir increases expression ISO CYP1A2 (Homo sapiens) 6480464 Ritonavir results in increased expression of CYP1A2 mRNA CTD PMID:11918509 ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of CYP1A2 mRNA CTD PMID:17719200 rofecoxib multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of Caffeine] and rofecoxib inhibits the reaction [CYP1A2 protein results in increased metabolism of tizanidine] CTD PMID:15834531 and PMID:16934051 rofecoxib decreases activity ISO CYP1A2 (Homo sapiens) 6480464 rofecoxib results in decreased activity of CYP1A2 protein CTD PMID:18816299 rubiadin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 rubiadin results in decreased activity of CYP1A2 protein CTD PMID:33438235 Rutecarpine multiple interactions EXP 6480464 rutecarpine promotes the reaction [CYP1A2 protein affects the metabolism of Theophylline] CTD PMID:15720787 Rutecarpine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 rutecarpine analog binds to and results in decreased activity of CYP1A2 protein and rutecarpine binds to and results in decreased activity of CYP1A2 protein CTD PMID:12852960 Rutecarpine increases activity EXP 6480464 rutecarpine results in increased activity of CYP1A2 protein CTD PMID:15720787 safrole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Safrole results in decreased activity of CYP1A2 protein CTD PMID:15778010 safrole increases expression ISO Cyp1a2 (Mus musculus) 6480464 Safrole results in increased expression of CYP1A2 mRNA CTD PMID:8722114 salicylamide multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 salicylamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:14729655 Salinomycin increases expression ISO CYP1A2 (Homo sapiens) 6480464 salinomycin results in increased expression of CYP1A2 mRNA CTD PMID:34806536 sanguinarine multiple interactions EXP 6480464 sanguinarine inhibits the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A2 protein] and sanguinarine results in decreased expression of and results in decreased activity of CYP1A2 protein CTD PMID:19788401 saracatinib increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of saracatinib CTD PMID:27769111 scutellarein affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of scutellarein CTD PMID:19666078 secobarbital increases expression ISO Cyp1a2 (Mus musculus) 6480464 Secobarbital results in increased expression of CYP1A2 mRNA CTD PMID:10064569 selenium atom multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] CTD PMID:21424224 senecionine increases expression ISO CYP1A2 (Homo sapiens) 6480464 senecionine results in increased expression of CYP1A2 mRNA CTD PMID:26100227 senecionine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 senecionine results in decreased expression of CYP1A2 mRNA CTD PMID:31606820 Sesamex increases expression ISO Cyp1a2 (Mus musculus) 6480464 sesamex results in increased expression of CYP1A2 mRNA CTD PMID:8722114 Shikonin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 Shikonin decreases activity EXP 6480464 shikonin results in decreased activity of CYP1A2 protein CTD PMID:28941798 silicon dioxide decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP1A2 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO CYP1A2 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of CYP1A2 mRNA CTD PMID:25351596 simazine increases activity EXP 6480464 Simazine results in increased activity of CYP1A2 protein CTD PMID:9711812 simazine decreases response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in decreased susceptibility to Simazine CTD PMID:26771455 simazine increases expression EXP 6480464 Simazine results in increased expression of CYP1A2 protein CTD PMID:9711812 sinensetin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of sinensetin CTD PMID:19666078 skatole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Skatole results in increased expression of CYP1A2 mRNA and Skatole results in increased expression of CYP1A2 protein CTD PMID:28571685 and PMID:31201936 sodium arsenite multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 sodium arsenite inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A2 mRNA] more ... CTD PMID:11162773 and PMID:20188822 sodium arsenite increases methylation ISO CYP1A2 (Homo sapiens) 6480464 sodium arsenite results in increased methylation of CYP1A2 intron CTD PMID:32844245 sodium arsenite decreases expression ISO Cyp1a2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CYP1A2 mRNA CTD PMID:17451858 and PMID:25065748 sodium arsenite increases expression ISO Cyp1a2 (Mus musculus) 6480464 sodium arsenite results in increased expression of CYP1A2 mRNA and sodium arsenite results in increased expression of CYP1A2 protein CTD PMID:22535251 and PMID:29044176 sodium arsenite multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 sodium arsenite inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:22535251 and PMID:36893905 sodium arsenite decreases expression ISO CYP1A2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP1A2 and sodium arsenite results in decreased expression of CYP1A2 mRNA CTD PMID:23052196 more ... sodium arsenite decreases activity ISO CYP1A2 (Homo sapiens) 6480464 sodium arsenite results in decreased activity of CYP1A2 protein CTD PMID:11162773 sodium dichromate multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of CYP1A2 mRNA CTD PMID:22613061 sodium fluoride decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of CYP1A2 mRNA CTD PMID:21340527 sophoraflavanone B increases expression ISO CYP1A2 (Homo sapiens) 6480464 8-prenylnaringenin results in increased expression of CYP1A2 mRNA CTD PMID:15672752 sophoraflavanone B decreases activity ISO CYP1A2 (Homo sapiens) 6480464 8-prenylnaringenin results in decreased activity of CYP1A2 protein CTD PMID:19770484 sporidesmin A affects expression ISO CYP1A2 (Homo sapiens) 6480464 sporidesmin affects the expression of CYP1A2 mRNA CTD PMID:28193462 sterigmatocystin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin] which results in increased chemical synthesis of Sterigmatocystin metabolite and CYP1A2 protein results in increased glutathionylation of and results in increased hydroxylation of Sterigmatocystin CTD PMID:20929267 steviol increases expression ISO CYP1A2 (Homo sapiens) 6480464 steviol results in increased expression of CYP1A2 mRNA and steviol results in increased expression of CYP1A2 protein CTD PMID:28887089 stevioside increases expression ISO CYP1A2 (Homo sapiens) 6480464 stevioside results in increased expression of CYP1A2 mRNA and stevioside results in increased expression of CYP1A2 protein CTD PMID:28887089 streptozocin decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Streptozocin results in decreased expression of CYP1A2 protein CTD PMID:12700423 streptozocin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of CYP1A2 mRNA CTD PMID:29127188 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of CYP1A2 mRNA CTD PMID:25905778 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP1A2 mRNA and [Streptozocin results in increased expression of CYP1A2 protein] which results in increased metabolism of Diazinon CTD PMID:17442507 and PMID:25905778 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP1A2 protein CTD PMID:17442507 styrene increases expression EXP 6480464 Styrene results in increased expression of CYP1A2 mRNA and Styrene results in increased expression of CYP1A2 protein CTD PMID:16418063 and PMID:18202523 styrene multiple interactions EXP 6480464 gadolinium chloride inhibits the reaction [Styrene results in increased expression of CYP1A2 protein] CTD PMID:18202523 Sudan I multiple interactions EXP 6480464 1-phenylazo-2-naphthol affects the expression of and affects the activity of CYP1A2 protein more ... CTD PMID:26845733 Sudan I increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 Sudan I multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYB5A protein promotes the reaction [CYP1A2 protein results in increased oxidation of 1-phenylazo-2-naphthol] CTD PMID:17159775 Sudan I increases expression EXP 6480464 1-phenylazo-2-naphthol results in increased expression of CYP1A2 mRNA CTD PMID:26845733 Sudan III increases expression EXP 6480464 sudan III results in increased expression of CYP1A2 protein CTD PMID:20308224 sulfaphenazole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Sulfaphenazole results in decreased activity of CYP1A2 protein CTD PMID:15916432 sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of CYP1A2 protein CTD PMID:15906351 sulforaphane multiple interactions EXP 6480464 sulforaphane results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] CTD PMID:22664424 sulforaphane multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 sulforaphane inhibits the reaction [1 more ... CTD PMID:19202560 and PMID:19362136 sulforaphane decreases expression ISO CYP1A2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of CYP1A2 mRNA CTD PMID:20442190 sulfur dioxide decreases activity EXP 6480464 Sulfur Dioxide results in decreased activity of CYP1A2 protein CTD PMID:16023800 sulfur dioxide decreases expression EXP 6480464 Sulfur Dioxide results in decreased expression of CYP1A2 mRNA CTD PMID:16023800 sulindac increases expression ISO CYP1A2 (Homo sapiens) 6480464 Sulindac results in increased expression of CYP1A2 mRNA CTD PMID:17985343 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of CYP1A2 mRNA CTD PMID:24136188 sulindac increases expression EXP 6480464 Sulindac results in increased expression of CYP1A2 mRNA CTD PMID:16531450 sulindac sulfide increases expression ISO CYP1A2 (Homo sapiens) 6480464 sulindac sulfide results in increased expression of CYP1A2 mRNA CTD PMID:17985343 sulpiride multiple interactions EXP 6480464 Sulpiride inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] CTD PMID:26466350 sulpiride decreases expression EXP 6480464 Sulpiride results in decreased expression of CYP1A2 mRNA CTD PMID:26466350 sunitinib increases expression EXP 6480464 sunitinib results in increased expression of CYP1A2 mRNA CTD PMID:26797788 sunitinib increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Sunitinib metabolite CTD PMID:29847931 sunitinib increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Sunitinib CTD PMID:29847931 sunitinib multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of Sunitinib] which results in increased chemical synthesis of Sunitinib metabolite CTD PMID:29847931 Sunset Yellow FCF multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of CYP1A2 mRNA CTD PMID:33819548 suramin decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Suramin results in decreased activity of CYP1A2 protein CTD PMID:11124226 tacrine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Chloroquine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine] more ... CTD PMID:18493746 and PMID:7946932 tacrine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Tacrine CTD PMID:7946932 tacrine multiple interactions EXP 6480464 Tacrine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 tacrine decreases activity EXP 6480464 Tacrine results in decreased activity of CYP1A2 protein CTD PMID:15258105 tacrine affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Tacrine CTD PMID:15258105 tamarixetin increases expression ISO CYP1A2 (Homo sapiens) 6480464 tamarixetin results in increased expression of CYP1A2 mRNA CTD PMID:19034627 tamoxifen increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Tamoxifen CTD PMID:15587933 tamoxifen increases activity ISO CYP1A2 (Homo sapiens) 6480464 Tamoxifen metabolite results in increased activity of CYP1A2 protein CTD PMID:29285606 tamoxifen increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Tamoxifen CTD PMID:29285606 tamoxifen multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Tamoxifen more ... CTD PMID:23397584 and PMID:29285606 tamoxifen decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Tamoxifen results in decreased activity of CYP1A2 protein CTD PMID:18420780 tangeretin multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 tangeretin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:17090139 tangeretin increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of tangeretin CTD PMID:29626627 Tanshinone I multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Dactinomycin inhibits the reaction [tanshinone results in increased expression of CYP1A2 mRNA] more ... CTD PMID:21262253 Tanshinone I increases expression ISO CYP1A2 (Homo sapiens) 6480464 tanshinone results in increased expression of CYP1A2 mRNA and tanshinone results in increased expression of CYP1A2 protein CTD PMID:21262253 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of CYP1A2 mRNA CTD PMID:15885361 tebuconazole increases expression ISO Cyp1a2 (Mus musculus) 6480464 tebuconazole results in increased expression of CYP1A2 mRNA CTD PMID:25656644 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP1A2 mRNA and tebuconazole results in increased expression of CYP1A2 protein CTD PMID:29923317 and PMID:30458266 tebuconazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] more ... CTD PMID:30458266 and PMID:33575850 tebuconazole increases activity ISO CYP1A2 (Homo sapiens) 6480464 tebuconazole results in increased activity of CYP1A2 protein CTD PMID:30458266 tebuconazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 tebuconazole results in increased expression of CYP1A2 mRNA CTD PMID:30458266 and PMID:33575850 tebuconazole multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 promotes the reaction [tebuconazole results in increased expression of CYP1A2 mRNA] CTD PMID:25656644 tegaserod decreases activity ISO CYP1A2 (Homo sapiens) 6480464 tegaserod results in decreased activity of CYP1A2 protein CTD PMID:11560869 terbutryn increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of terbutryne CTD PMID:8971136 terbutryn multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 POR protein promotes the reaction [CYP1A2 protein results in increased metabolism of terbutryne] CTD PMID:8971136 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CYP1A2 mRNA CTD PMID:21515302 tetrachloroethene increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 tetrachloroethene decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of CYP1A2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO Cyp1a2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA and Carbon Tetrachloride results in decreased expression of CYP1A2 protein CTD PMID:16445600 more ... tetrachloromethane increases expression ISO Cyp1a2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CYP1A2 mRNA and Carbon Tetrachloride results in increased expression of CYP1A2 protein CTD PMID:24646716 tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of CYP1A2 protein CTD PMID:14706259 and PMID:16288784 tetrachloromethane increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Carbon Tetrachloride CTD PMID:15988118 tetrachloromethane multiple interactions EXP 6480464 2-amino-3 more ... CTD PMID:16288784 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP1A2 mRNA and Carbon Tetrachloride results in decreased expression of CYP1A2 protein CTD PMID:14706259 more ... tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of CYP1A2 mRNA CTD PMID:15963342 tetrachloromethane multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of CYP1A2 mRNA more ... CTD PMID:17084009 more ... tetrahydrocurcumin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 tetrahydrocurcumin inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] CTD PMID:26102010 tetrahydropalmatine decreases expression ISO Cyp1a2 (Mus musculus) 6480464 tetrahydropalmatine results in decreased expression of CYP1A2 mRNA and tetrahydropalmatine results in decreased expression of CYP1A2 protein CTD PMID:28257954 tetraphene multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of benz(a)anthracene and EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of benz(a)anthracene] CTD PMID:8961944 tetraphene multiple interactions EXP 6480464 [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene] results in increased expression of CYP1A2 mRNA and [chrysene co-treated with Benzo(a)pyrene co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA CTD PMID:37189300 tetraphene increases expression EXP 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:21384493 and PMID:23358148 tetraphene increases expression ISO CYP1A2 (Homo sapiens) 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:17253728 and PMID:9783729 tetraphene decreases activity ISO CYP1A2 (Homo sapiens) 6480464 benz(a)anthracene results in decreased activity of CYP1A2 protein CTD PMID:11162773 tetraphene affects response to substance EXP 6480464 CYP1A2 protein affects the susceptibility to benz(a)anthracene CTD PMID:21384493 tetraphene increases expression ISO Cyp1a2 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of CYP1A2 mRNA CTD PMID:17825862 tetraphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [andrographolide co-treated with benz(a)anthracene] results in increased expression of CYP1A2 mRNA more ... CTD PMID:17825862 more ... theobromine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Theobromine CTD PMID:10215755 theobromine increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Theobromine CTD PMID:1302044 theobromine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased chemical synthesis of Theobromine and furafylline affects the reaction [CYP1A2 protein results in increased metabolism of Theobromine] CTD PMID:10215755 and PMID:31132250 theophylline multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein binds to and results in increased metabolism of Caffeine] which results in increased chemical synthesis of Theophylline more ... CTD PMID:11408986 more ... theophylline increases chemical synthesis ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased chemical synthesis of Theophylline CTD PMID:1302044 theophylline affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP affects the susceptibility to Theophylline CTD PMID:12732846 theophylline affects hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 promoter SNP affects the hydroxylation of Theophylline CTD PMID:16841220 theophylline affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 gene SNP affects the metabolism of Theophylline and CYP1A2 protein affects the metabolism of Theophylline CTD PMID:12732846 more ... theophylline increases metabolic processing EXP 6480464 CYP1A2 protein results in increased metabolism of Theophylline CTD PMID:20096675 theophylline increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Theophylline CTD PMID:11483122 and PMID:9701106 theophylline multiple interactions EXP 6480464 andrographolide affects the reaction [CYP1A2 protein results in increased metabolism of Theophylline] more ... CTD PMID:15720787 and PMID:20096675 theophylline affects metabolic processing ISO Cyp1a2 (Mus musculus) 6480464 CYP1A2 protein affects the metabolism of Theophylline CTD PMID:15970798 theophylline affects metabolic processing EXP 6480464 CYP1A2 protein affects the metabolism of Theophylline CTD PMID:15720787 and PMID:15985363 theophylline decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Theophylline results in decreased activity of CYP1A2 protein CTD PMID:11465391 thiabendazole multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] CTD PMID:10936227 thiabendazole increases expression EXP 6480464 Thiabendazole results in increased expression of CYP1A2 mRNA and Thiabendazole results in increased expression of CYP1A2 protein CTD PMID:15110098 and PMID:18539377 thiabendazole affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Thiabendazole CTD PMID:10936227 and PMID:12920490 thiabendazole increases expression ISO CYP1A2 (Homo sapiens) 6480464 Thiabendazole results in increased expression of CYP1A2 mRNA CTD PMID:18570159 thiabendazole decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Thiabendazole results in decreased activity of CYP1A2 protein CTD PMID:11124226 and PMID:16261361 thiacloprid increases expression ISO CYP1A2 (Homo sapiens) 6480464 thiacloprid results in increased expression of CYP1A2 mRNA and thiacloprid results in increased expression of CYP1A2 protein CTD PMID:21784029 and PMID:32201337 thiacloprid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [enilconazole co-treated with thiacloprid co-treated with clothianidin] results in increased expression of CYP1A2 mRNA and [thiacloprid co-treated with enilconazole] results in increased expression of CYP1A2 mRNA CTD PMID:32201337 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP1A2 mRNA CTD PMID:23411599 and PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of CYP1A2 mRNA CTD PMID:28943392 thiophanate-methyl increases expression EXP 6480464 Thiophanate results in increased expression of CYP1A2 protein CTD PMID:10096430 thioridazine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine and CYP1A2 protein results in increased metabolism of and results in increased activity of Thioridazine CTD PMID:19482014 and PMID:23397584 ticlopidine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite and Ticlopidine inhibits the reaction [CYP1A2 protein results in increased oxidation of 4-amino-2-phenoxymethanesulfonanilide] CTD PMID:19053182 and PMID:19170597 ticlopidine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Ticlopidine results in decreased activity of CYP1A2 protein CTD PMID:10759690 tizanidine affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of tizanidine CTD PMID:15592331 and PMID:16198659 tizanidine increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of tizanidine CTD PMID:17618427 tizanidine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [[Ethinyl Estradiol co-treated with Gestodene] results in decreased activity of CYP1A2 protein] which results in decreased metabolism of tizanidine more ... CTD PMID:15592331 more ... tofacitinib increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of tofacitinib CTD PMID:31414593 tolcapone multiple interactions EXP 6480464 tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 tolcapone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 tolcapone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A2 protein] CTD PMID:18493746 tolcapone increases expression EXP 6480464 tolcapone results in increased expression of CYP1A2 mRNA CTD PMID:24136188 tolfenamic acid decreases activity ISO CYP1A2 (Homo sapiens) 6480464 tolfenamic acid results in decreased activity of CYP1A2 protein CTD PMID:17618427 and PMID:18816299 tolfenamic acid multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 ALB protein inhibits the reaction [tolfenamic acid results in decreased activity of CYP1A2 protein] CTD PMID:17618427 toluene multiple interactions EXP 6480464 Acetone promotes the reaction [Toluene results in increased expression of CYP1A2 protein] and Methylcholanthrene promotes the reaction [CYP1A2 protein results in increased oxidation of Toluene] CTD PMID:1994898 and PMID:8996725 toluene increases expression EXP 6480464 Toluene results in increased expression of CYP1A2 protein CTD PMID:8996725 toluene increases oxidation EXP 6480464 CYP1A2 protein results in increased oxidation of Toluene CTD PMID:1994898 toxaphene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Toxaphene results in increased expression of CYP1A2 mRNA CTD PMID:26187448 and PMID:28218408 toxaphene multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 NR1I3 gene mutant form inhibits the reaction [Toxaphene results in increased expression of CYP1A2 mRNA] CTD PMID:28218408 trabectedin decreases expression EXP 6480464 trabectedin results in decreased expression of CYP1A2 mRNA CTD PMID:12154027 trans-1,2-dichloroethene decreases activity EXP 6480464 1 and 2-dichloroethylene results in decreased activity of CYP1A2 protein CTD PMID:9671540 trans-1,2-dichloroethene affects expression EXP 6480464 1 and 2-dichloroethylene affects the expression of CYP1A2 protein CTD PMID:9493318 trans-chalcone increases hydroxylation EXP 6480464 CYP1A2 protein results in increased hydroxylation of Chalcone CTD PMID:15863696 tranylcypromine multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 tranylcypromine decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Tranylcypromine results in decreased activity of CYP1A2 protein CTD PMID:15916432 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP1A2 mRNA CTD PMID:20659493 triamterene increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Triamterene CTD PMID:16035375 triazines multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 alpha-naphthoflavone inhibits the reaction [CYP1A2 protein results in increased metabolism of Triazines] more ... CTD PMID:9305587 triazines increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of Triazines CTD PMID:9305587 Tributyltin oxide increases expression ISO CYP1A2 (Homo sapiens) 6480464 bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 mRNA and bis(tri-n-butyltin)oxide results in increased expression of CYP1A2 protein CTD PMID:21784029 trichloroethene increases expression ISO Cyp1a2 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CYP1A2 mRNA CTD PMID:19254012 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP1A2 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 trichostatin A promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] CTD PMID:12927368 trichostatin A multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [trichostatin A results in increased expression of CYP1A2 mRNA] CTD PMID:15252868 trichostatin A increases expression ISO Cyp1a2 (Mus musculus) 6480464 trichostatin A results in increased expression of CYP1A2 mRNA CTD PMID:15252868 trichostatin A increases expression ISO CYP1A2 (Homo sapiens) 6480464 trichostatin A results in increased expression of CYP1A2 mRNA CTD PMID:12927368 and PMID:28357125 triclosan increases expression ISO CYP1A2 (Homo sapiens) 6480464 Triclosan results in increased expression of CYP1A2 mRNA CTD PMID:29849464 triflumuron increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of triflumuron CTD PMID:31082524 triflumuron multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 furafylline inhibits the reaction [CYP1A2 protein results in increased metabolism of triflumuron] CTD PMID:31082524 trimethoprim multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Trimethoprim results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 trimethoprim decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Trimethoprim results in decreased activity of CYP1A2 protein CTD PMID:26599973 trimethylarsine oxide increases expression EXP 6480464 trimethylarsine oxide results in increased expression of CYP1A2 mRNA CTD PMID:17481689 trimethylarsine oxide increases expression ISO Cyp1a2 (Mus musculus) 6480464 trimethylarsine oxide results in increased expression of CYP1A2 mRNA and trimethylarsine oxide results in increased expression of CYP1A2 protein CTD PMID:26144063 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYP1A2 mRNA CTD PMID:30589522 triptonide increases expression ISO Cyp1a2 (Mus musculus) 6480464 triptonide results in increased expression of CYP1A2 mRNA CTD PMID:33045310 troglitazone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone CTD PMID:23397584 tryptamines multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [Tryptamines analog results in decreased activity of CYP1A2 protein] which results in decreased metabolism of Phenacetin CTD PMID:26599973 tryptamines decreases activity ISO CYP1A2 (Homo sapiens) 6480464 Tryptamines analog results in decreased activity of CYP1A2 protein CTD PMID:26599973 umbelliferone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased metabolism of coumarin] which results in increased abundance of 7-hydroxycoumarin CTD PMID:34334558 vadimezan multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] CTD PMID:16120190 vadimezan increases oxidation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased oxidation of vadimezan CTD PMID:16120190 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of CYP1A2 mRNA CTD PMID:24136188 valproic acid affects expression ISO Cyp1a2 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP1A2 mRNA CTD PMID:17292431 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP1A2 mRNA CTD PMID:35594946 valproic acid decreases expression ISO CYP1A2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:29501571 valproic acid increases methylation ISO CYP1A2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CYP1A2 gene CTD PMID:29501571 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP1A2 mRNA CTD PMID:17381134 vanadium atom multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] more ... CTD PMID:23423713 vanadium(0) multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 Vanadium inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein] more ... CTD PMID:23423713 vancomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA CTD PMID:30545405 veliparib increases metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased metabolism of veliparib CTD PMID:21436403 verapamil decreases activity ISO Cyp1a2 (Mus musculus) 6480464 Verapamil results in decreased activity of CYP1A2 protein CTD PMID:18420780 versicolorin A increases expression ISO CYP1A2 (Homo sapiens) 6480464 versicolorin A results in increased expression of CYP1A2 mRNA CTD PMID:32106047 vinclozolin multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein and [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein CTD PMID:17686559 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP1A2 protein CTD PMID:7986207 vitamin E affects expression EXP 401900296 Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart] RGD warfarin affects metabolic processing ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein affects the metabolism of Warfarin CTD PMID:14676821 and PMID:15280511 warfarin affects response to substance ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 SNP affects the susceptibility to Warfarin CTD PMID:28079798 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [INS1 protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA]] and wortmannin inhibits the reaction [INS1 protein results in decreased expression of CYP1A2 mRNA] CTD PMID:26466350 Wuweizisu C decreases activity ISO Cyp1a2 (Mus musculus) 6480464 schizandrin C results in decreased activity of CYP1A2 protein CTD PMID:25753323 xanthohumol increases expression ISO CYP1A2 (Homo sapiens) 6480464 xanthohumol results in increased expression of CYP1A2 mRNA CTD PMID:22138251 xanthohumol multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 xanthohumol inhibits the reaction [2-amino-3 more ... CTD PMID:22138251 yohimbine multiple interactions ISO Cyp1a2 (Mus musculus) 6480464 [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of CYP1A2 mRNA CTD PMID:28843594 zafirlukast multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 zafirlukast inhibits the reaction [CYP1A2 protein results in increased metabolism of Theophylline] CTD PMID:9701106 zaragozic acid A increases expression ISO Cyp1a2 (Mus musculus) 6480464 squalestatin 1 results in increased expression of CYP1A2 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP1A2 mRNA CTD PMID:27225895 zearalenone increases hydroxylation ISO CYP1A2 (Homo sapiens) 6480464 CYP1A2 protein results in increased hydroxylation of Zearalenone CTD PMID:19931366 zearalenone multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 [CYP1A2 protein results in increased hydroxylation of Zearalenone] which results in increased chemical synthesis of Catechols CTD PMID:19931366 zerumbone increases expression ISO CYP1A2 (Homo sapiens) 6480464 zerumbone results in increased expression of CYP1A2 mRNA CTD PMID:36122806 zileuton decreases activity ISO CYP1A2 (Homo sapiens) 6480464 zileuton results in decreased activity of CYP1A2 protein CTD PMID:14570767 zileuton multiple interactions ISO CYP1A2 (Homo sapiens) 6480464 zileuton inhibits the reaction [CYP1A2 protein results in increased metabolism of Phenacetin] CTD PMID:14570767 zinc atom multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] CTD PMID:21424224 zinc protoporphyrin multiple interactions EXP 6480464 [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein CTD PMID:26747958 zinc(0) multiple interactions EXP 6480464 [Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] CTD PMID:21424224 zoledronic acid increases expression ISO CYP1A2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of CYP1A2 mRNA CTD PMID:24714768 and PMID:25596134 zolmitriptan decreases activity ISO CYP1A2 (Homo sapiens) 6480464 zolmitriptan results in decreased activity of CYP1A2 protein CTD PMID:18816299